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Perturbation of the balance between self-renewal and differentiation of stem cell 
may result in developmental defects or cancer formation. In recent years, Drosophila 
larval brain neuroblasts (NBs) have emerged as a model for understanding stem cell 
self-renewal and tumor formation. In particular, newly-identified Drosophila type II 
neuroblasts that develop through the transit-amplifying phase of the intermediate neural 
progenitors (INPs) are susceptible to impaired homeostasis if the restricted proliferative 
ability of INPs is unrestrained. However, while it is known that there are several type II 
specific transcription factors that regulate INP formation and prevent de-differentiation, 
the precise nature of the molecular mechanism preventing de-differentiation is largely 
unknown. 
In this thesis, I demonstrate that Drosophila Brm chromatin remodeling complex 
regulates type II neuroblast homeostasis. Loss-of-function of brm resulted in ectopic 
neuroblasts formation within type II neuroblast lineages. Consistently, loss-of-function of 
the other components of Brm complex namely bap55, bap60, snr1 and mor caused type 
II neuroblast overgrowth phenotype. These suggest that Drosophila Brm complex 
regulates type II neuroblast homoeostasis. To determine if defects in asymmetric 
division is responsible for neuroblast over-growth in loss-of-function of brm, sub-cellular 
localization of asymmetric division regulators was analyzed. However, asymmetric 
localization of aPKC, Brat and Numb were not affected in brm mutant suggesting that 
Brm is not important for apico-basal polarity of neuroblast. In contrast, the number of 
immature INPs was increased while the number of mature INPs was reduced upon loss-
of-function of brm, suggesting a reversion of INP fate. Furthermore, knock down of brm 
ix 
 
specifically in INPs resulted in neuroblast formation, indicating that Brm suppresses INP 
de-differentiation back into type II neuroblasts.  
Next, we sought to identify histone modifiers that regulate neuroblasts 
homeostasis. In a genetic enhancer screen, knock down of histone deacetylase 3 
(hdac3) was observed to enhance neuroblast over-growth of brm knock down. 
Furthermore, loss-of-function of hdac3 similarly enhanced neuroblast over-growth of 
snr1. These obsevations suggest that HDAC3 functions synergistically with Brm complex 
in regulating type II neuroblast homeostasis. Consistently, Brm and HDAC3 physically 
associate as a protein complex in vitro. Since Brm complex and HDAC3 are ubiquitously 
expressed throughout the larval brain, it is likely that these epigenetic regulators function 
through a type II-specific transcription factor to confer the lineage specific function. 
Interestingly, Brm, Bap60, Snr1 and HDAC3 physically associate with Earmuff (Erm), a 
type II-specific zinc finger transcription factor, in vitro. Moreover, simultaneous knock 
down of erm with brm, snr1 or hdac3 resulted in significant enhancement of the 
phenotype of any of the single knock down. Further, loss-of-brm suppressed premature 
differentiation induced by ectopic expression of Erm.  
Together, this body of evidence suggests that the two epigenetic regulators, Brm 
complex and HDAC3 physically associate with Erm as a novel protein complex to 
regulate type II neuroblast homeostasis by suppressing INP de-differentiation. Findings 
in this thesis deepen our understanding of the SWI/SNF-mutated human cancers and 
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1.1 Drosophila melanogaster as model organism  
First introduced as experimental organism for evolutionary biology studies in 
early 20th century, the fruit fly Drosophila melanogaster has since emerged as an 
extensively used genetic model (Carlson, E.O. 2004; Kohler, R.E. 1994). In recent 
decades, Drosophila has rapidly emerged as an ideal animal model for various biological 
as well as biomedical researches (Jennings, B.H. 2011). Its small size coupled with short 
life cycle, low chromosome number and ease of culture and maintenance make fruit fly 
widely adopted for experimental investigation (Jennings, B.H. 2011). With the advent of 
technologies, various genetic and molecular tools were developed that facilitate 
Drosophila research. A landmark in Drosophila research is the complete sequencing of 
its genome (Myers et al, 20000; Adams et al, 2000). Comparing its genomic sequence to 
that of the human genome, it was reported that approximately 75% of genes associated 
with human cancers and diseases exist in the fly genome (Reiter et al, 2001). This 
parallel is instrumental in making Drosophila the model for studying various aspects of 
development, behavior and diseases of human. Further, the development of dsRNA and 
microarray technology make genome-wide screen and analysis of fundamental 
processes possible in the fruit fly, in which the results could be extended to human 
(Arias, A.M. 2008). Moreover, Drosophila is an emerging asset in clinical drug discovery. 
It can be used to test the effect of drugs on conserved biochemical pathways in a high 
throughput manner with potential of providing initial safety profile of the tested drugs 
(Pandey and Nichols, 2011). Indubitably, Drosophila is an excellent model for studies of 
conserved processes with potential of providing clinical values. 
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1.2 Drosophila larval brain neuroblasts as a model system for stem cell biology 
 The neural stem cells, called neuroblasts (NB), in the developing brain of 
Drosophila have emerged as a major model system for neural stem cell biology. Despite 
Drosophila being a simple invertebrate, many of the key features of mammalian 
neurogenesis can be recapitulated in neuroblasts (Homem and Knoblich, 2012). Similar 
to mammalian neural stem cells, Drosophila neuroblasts proliferate in a spatially and 
temporally regulated fashion to generate a repertoire of neurons that make up the 
complex brain of the adult fruit fly (Yang, Yeo et al. 1993; Yang, Bahri et al. 1997; 
Urbach and Technau 2003; Karcavich 2005). Furthermore, neuroblasts enter and exit 
cell cycle in a fashion that is developmentally synchronized to ensure the timely 
generation of neurons while restricting proliferation that could contribute to tumor 
formation (Maurange et al, 2008; Chell and Brand, 2010; Sousa-Nunes et al, 2011). In 
addition, various aspects of the intrinsic machinery that regulate the asymmetric division 
of neuroblasts are similarly observed in mammalian neural stem cells (Homem and 
Knoblich, 2012). Coupled with the advanced genetic tools of Drosophila, the relatively 
simple development of the neuroblasts allow numerous insights to be made on the 
mechanisms that regulate neuroblasts, which correspond to those of the mammalian 
neural stem cells.  Thus, Drosophila neuroblasts are excellent model for studies on 
neural stem cell biology that allows understanding into neural development and 
formation of brain tumor. 
 
1.3 Neurogenesis in Drosophila  
Development of the central nervous system in Drosophila occurs at two distinct 
neurogenic phases, one during embryogenesis and another during larval development 
(Fig. 1C; Homem and Knoblich, 2012; Sousa.Nunes and Somers, 2013). Embryonic 
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neurogenesis generates neurons that populate the larval brain while larval neurogenesis 
generates secondary neurons that make up the functional brain of adult fruit fly (Homem 
and Knoblich, 2012; Sousa.Nunes and Somers, 2013). 
 
Fig. 1: Neurogenesis in Drosophila. (A) Schematic representation of Drosophila stage 
9 embryo with the ventral neuroectoderm (vNR) and procephalic neuroectoderm (pNR) 
shown. (B) Enlarged view of the boxed vNR in Drosophila embryo. Neuroblasts (NBs) 
delaminate from vNR, undergo spindle rotation to divide perpendicular to the 
neuroectodermal layer. Neuroblast divides asymmetrically to generate a self-renewing 
neuroblast and a differentiating ganglion mother cell (GMC). (C) Timeline of Drosophila 
neurogenesis. Embryonic neuroblasts divide without re-growing resulting in cell size 
reduction. Eventually they enter quiescence at late embryonic stage. At late first instar 
larval stage, NBs re-enter cell cycle and start dividing until 24hrs after puparium 





1.3.1 Embryonic Neurogenesis 
Drosophila neuroblasts are first formed shortly after gastrulation during 
embryonic stage 9-11 (Homem and Knoblich, 2012; Hartenstein and Wodarz, 2012). 
During early embryonic development, ectoderm is patterned to develop into the 
epidermal ectoderm or the neuroectoderm (Campos-Ortega, 1995). The ventral 
neuroectoderm (vNR), which is shaped as a columnar epithelium comprising of 
approximately 100 cells in length and 8-9 cells in width, generates the ventral nerve cord 
(VNC) of Drosophila (Fig. 1a; Campos-Ortega and Hartenstein, 1984). In contrast, the 
smaller procephalic neuroectoderm (pNR) residing in the embryonic head develops into 
the brain hemispheres (Fig. 1a; Hartenstein and Wodarz, 2012). Prepatterning genes, 
namely ventral nerve cord defective (Vnd) (Chu et al, 1998; McDonald et al, 1998), 
intermediate neuroblasts defective (Ind) (Weiss et al, 1998) and muscle-specific 
homeobox gene (Msh) (Isshiki et al, 1997) are expressed in longitudinal stripes along 
the antero-posterior axis (A-P) that correspond to the medial, intermediate and lateral 
column of ventral neuroectoderm (von Ohlen and Doe, 2000). Together with the 
segment polarity genes and pair rule genes that are expressed in transverse columns, 
the prepatterning genes activate the expression of proneural genes in 10 groups of 6-8 
cells per side of a bilaterally symmetric segment (hemisegment). (Cabrera et al, 1987; 
Skeath and Carroll, 1992; Skeath et al, 1992) These groups are termed as “Proneural 
clusters” and each cluster generates only one neuroblast. The proneural genes 
comprising of Achaete (Ac), Scute (Sc) and lethal of scute (L’sc) confer all cells within 
each cluster with the ability to develop into neuroblasts.  
Selection of a single neuroblast within each proneural cluster occurs via the 
Notch (N)-mediated lateral inhibition (Bray, 1998; Heitzler et al, 1996). N and its ligand 
Delta (Dl) are transmembrane proteins that are widely expressed in the neuroectoderm 
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(Hartenstein and Wodarz, 2013). Upon binding by Dl, N undergoes a proteolytic 
cleavage resulting in the release of the intracellular domain, termed as Notch 
intracellular domain (NICD), that enters into the nucleus where it binds with the 
Suppressor of Hairless (Su(H)) and induces expression of the basic helix-loop-helix 
(bHLH) Enhancer of Split (E(Spl)) transcription factors (Hartenstein and Wodarz, 2013). 
E(Spl) functions with Groucho (Gro) to repress the transcription of proneural genes 
causing these cells to lose the potential to develop into neuroblasts and initiate 
epidermal fate (Artavanis-Tsakonas et al, 1999). Concurrently, the prospective 
neuroblast within each cluster maintains its expression of the proneural genes, which in 
turn feedback to activate the expression of Dl and neural genes (Hartenstein and 
Wodarz, 2013). Since all cells within a proneural cluster express both N and Dl in 
overlapping pattern, they are equally likely to acquire neural or epidermal fate. However, 
one of the cells would acquire bias to be the N signaling cell and thus become 
neuroblast, though the exact mechanism of such bias is uncertain. One postulation is 
that the inhibitory cis-interaction between N and Dl residing on the membrane of the 
same cell could effect the lateral inhibition (Barad et al, 2010; Hartenstein and Wodarz, 
2013). In a stochastic fashion, when the number of Dl on the membrane exceeds the 
number of N receptors on the membrane of the same cell, all the N receptors would be 
bound by the cis Dl without activation (Barad et al, 2010; Jacobsen et al, 1998; Li et al, 
2004; Hartenstein and Wodarz, 2013). As a result, these receptors could no longer 
respond to Dl of neighboring cells while its remaining Dl molecules could bind and 
activate N signaling in those neighboring cells (Barad et al, 2010; Jacobsen et al, 1998; 
Li et al, 2004; Hartenstein and Wodarz, 2013). Through this cis-inhibitory signaling, 
lateral inhibition could occur with high fidelity to ensure that only one neuroblast is 
generated from each proneural cluster (Jacobsen et al, 1998; Li et al, 2004). 
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Within each proneural cluster, the selected prospective neuroblast would then 
undergo rapid changes in cell size, shape and nuclear position in preparation for 
delamination (Hartenstein and Wodarz, 2013). Neuroblast delamination is synchronized 
with mitotic division. The N-mediated lateral inhibition occurs during the G2 phase of the 
14th cell cycle (Hartenstein and Wodarz, 2013). Nuclei of the presumptive 
epidermoblasts translocate apically and cells enter into mitosis, whereas nucleus of the 
presumptive neuroblast remains at the basal side and cell mitosis is postponed 
(Hartenstein and Wodarz, 2013). The latter then undergoes changes in cell shape in 
preparation for delamination (Hartenstein and Wodarz, 2013). The presumptive 
neuroblast retains a slender process that contacts with the apical surface. However, this 
connection is subsequently lost allowing the neuroblast to separate from the ectodermal 
layer (Fig. 1B; Hartenstein and Wodarz, 2013).  
Approximately 30 neuroblasts delaminate in each hemisegment through five 
successive waves, S1 to S5, and are arranged in a stereotypic orthogonal array of five 
rows (Sousa-Nunes and Somers; Hartenstein and Wodarz, 2013). Once segregated, 
neuroblasts enter into mitosis with the mitotic spindle orients perpendicular to the plane 
of the apical ectoderm (Fig. 1B; Kaltschmidt et al, 2000; Rebollo et al, 2009). The 
delaminated neuroblast undergoes asymmetric division to generate a larger self-
renewing neuroblast and a smaller cell called the ganglion mother cell (GMC) (Fig. 1B; 
Homem and Knoblich, 2012; Sousa-Nunes and Somers, 2014). The latter then 
undergoes a terminal division to generate two post-mitotic neurons or glia. Embryonic 
neuroblasts undergo approximately 12 rounds of asymmetric division, which in total 
generates approximately 350 post-mitotic neurons per thoracic hemisegment (Chang et 
al, 2012). The neurons generated during embryonic neurogenesis populate the larval 
central brain and VNC, however, make up less than 10% of the adult Drosophila central 
nervous system (CNS) (Homem and Knoblich, 2012). 
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With each cell division, embryonic neuroblasts shrink in cell size, decreasing 
from approximately 11μm to 4μm (Hartenstein et al, 1987; Truman and Bate, 1988). As 
a result, neuroblasts enter into quiescence at the end of embryonic neurogenesis at 
stage 15 (Prokop and Technau, 1991; Tsuji et al, 2008).  
 
1.3.2 Post-embryonic Neurogenesis  
 The second phase of neurogenesis occurs in the larval stage and is responsible 
for generating 90% of neurons that populate the complex brain of the adult fruit fly 
(Homem et al, 2012). At the late first instar larval stage, sustained nutrition triggers 
neuroblasts to exit quiescence and reactivate proliferation (Britton and Edgar, 1998). 
Larval neuroblasts re-activation proceeds in an anterior to posterior wave starting with 
neuroblasts in the central brain, followed by those in the thoracic VNC and ending with 
neuroblasts residing in the abdominal and terminal VNC (Truman et al, 1994).  
With feeding, level of circulating amino acids increases and activates the adipose 
hepatic-like fat body. Circulating amino acids are detected by fat body through the amino 
acid transporter, Slimfast (Slif), which triggers the target of Rapamycin (TOR) pathway 
(Britton and Edgar, 1998). In turn, fat body releases an unidentified mitogen known as 
the Fat Body-Derived Mitogen (FBDM) that activates the phosphatidylinositol 3-kinase 
(PI3K) and TOR pathway in glial cells (Britton and Edgar, 1998).  This induces glia to 
release Insulin like peptides (ILPs), which bind and activate Insulin receptors on the 
quiescent neuroblasts, triggering the downstream PI3K/TOR pathway (Chell and Brand, 
2010; Sousa-Nunes et al, 2010). Simultaneously, circulating amino acids could also 
activate TOR pathway in dormant neuroblasts. With activation of InR and TOR pathway 
in quiescent neuroblasts, protein biosynthesis occurs leading to cell growth and inhibition 
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of FOXO transcription factor, which trigger neuroblasts to enter cell division (Chell and 
Brand, 2010; Sousa-Nunes et al, 2010).  
Apart from the extrinsic regulation by nutrition, the timing of cell cycle activation 
following exit from neuroblast quiescence is also regulated by two intrinsic factors 
encoded by anachronism (ana) and terribly reduced optic lobes (trol) (Datta, S., 1995; 
Ebens et al, 1993). Ana, a glycoprotein secrete by glia, functions to prevent S-phase 
initiation in neuroblasts, which in turn prevents pre-mature exit from quiescence (Ebens 
et al, 1993). On the other hand, the heparan sulfate proteoglycan Trol functions 
downstream of Ana to initiate G1 to S phase transition for exit from quiescence (Datta, 
S., 1995). 
Once exit from quiescence, central brain neuroblasts in the larval brain divide 
asymmetrically to generate neurons. Unlike embryonic neurogenesis, larval stage 
neuroblasts undergo growth phase (G1 phase) to regain in size before continuing the 
next division. As such, post-mitotic neuroblasts are able to undergo approximately 50-
100 asymmetric divisions throughout the entire larval development (Ito and Hotta 1992; 
Chang, Wang et al. 2012).  
 
1.4 Intrinsic regulation of neuroblast asymmetric cell division 
 Asymmetric cell division is a process that generates two daughter cells of 
different cell fates (Chang et al, 2012; Sousa-Nunes and Somers, 2013; Homem and 
Knoblich, 2012). This mode of division is widely employed by various stem cells to 
uphold an intricate balance between self-renewal to maintain the stem cell pool and 
generation of differentiated cells for organogenesis and homeostasis (Chang et al, 
2012). Various stem cell populations in Drosophila have emerged as instructive models 
of asymmetric division (Knoblich 2008). These include the sensory organ precursor cells 
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that generate the four cells present in external sensory organs, neuroblasts and germline 
stem cells (Knoblich 2008). Among these models, neuroblasts are imperative model for 
intrinsic regulation of asymmetric division of neural stem cells, providing numerous 
mechanistic insights (Knoblich 2008).  
Assumption of distinct cell fates by daughter cells can be regulated by extrinsic or 
intrinsic cues (Chang et al, 2012; Yu et al, 2006; Chia et al, 2008). Extrinsic mechanism 
involves external cues to mediate the adoption of different cell fates (Chang et al, 2012). 
Under this mechanism, daughter cells of identical fate are generated. However, owing to 
the differences in their relative spatial placement, the two daughter cells are exposed to 
different external cues and thus acquire different developmental fates (Yong and Yan, 
2011; Chang et al, 2012). On the contrary, intrinsic mechanism involves the asymmetric 
inheritance of cell fate determinants by the two daughter cells (Yong and Yan, 2011). 
Drosophila neuroblasts of different lineages and at different developmental stages 
regulate the distinct cell fates of their daughter cells through a common mechanism of 
asymmetric segregation of intrinsic cell fate determinants. Nonetheless, It was 
demonstrated that asymmetric protein localization occurs during the onset of mitosis in 
primary culture of neuroblasts unlike in the larval brain neuroblasts, where it occurs 
during late interphase (Ceron et al, 2006). As such, though extrinsic cues are not 
required for proper neuroblast asymmetry, it might however, be required for timely onset 
of neuroblast asymmetry (Broadus and Doe, 1997). Asymmetric cell division of 
neuroblasts involves three key steps: establishment of neuroblast polarity, proper 
orientation of mitotic spindle and asymmetric localization and segregation of cell fate 




Fig. 2: Intrinsic regulation of neuroblast asymmetric division. Apical (green) and 
basal (red) proteins are asymmetrically localized at the cortex of mitotic neuroblasts. The 
Par complex, which comprises of Baz, Par-6 and aPKC establishes cell polarity. Several 
proteins including PP2A, AurA, Lgl, Cdc42, Zif and Dap160 regulate the Par complex. 
The Gαi-Pins-Loco complex, which is linked through Insc to the Par complex, regulates 
mitotic spindle orientation either through Dlg-Khc73 complex or Mud. In addition, Mud 
could also function with Ctp-Ana2 complex to regulate mitotic spindle orientation. Basally 
localized Mira-Pros-Brat complex and Pon-Numb complex regulate differentiation in 
ganglion mother cell independent of each other. Basal localization of Numb and Mira is 
regulated through direct phosphorylation by aPKC or indirectly through aPKC-mediated 
phosphorylation of Lgl. Acto-myosin dependent pathway (through Zip and Jar) could also 








1.4.1 Establishment of neuroblast polarity  
The evolutionarily conserved Par complex, which comprises of the Partitioning-
defective 3 (Par-3), also known as Bazooka (Baz), Par-6 and atypical Protein Kinase C 
(aPKC), is the first entity to localize to the inner face of cell membrane, called the cell 
cortex, at the apical side (Fig. 3; Sousa-Nunes and Somers, 2013; Yu et al, 2006). This 
protein complex provides the first polarity cue in neuroblasts. It is inherited from the 
epithelial cells when the specified neuroblasts delaminate from the neuroectoderm (Fig. 
1; Sousa-Nunes and Somers, 2013; Yu et al, 2006). During delamination, neuroblasts 
maintain contact with the overlying neuroectoderm via an “apical stalk” where Par 
complex is localized (Fig. 1; Yu et al, 2006). Subsequently, embryonic neuroblasts 
maintain apical localization of the Par complex and divide asymmetrically along the 
apical-basal axis of the overlying epithelium (Fig. 1; Sousa-Nunes and Somers, 2013; Yu 
et al, 2006). Post-embryonic neuroblasts, on the other hand, align the apical-basal axis 
relative to the axis of previous division, potentially using centrosome as reference 
(Sousa-Nunes and Somers, 2013).  
Baz is the first component of the Par complex to be recruited to the apical cortex 
of epithelial cells (Harris and Peifer, 2005). It is a large PDZ (Post-synaptic density 
protein, Drosophila Disc larger tumor suppressor, and Zonula occluden-1 protein) 
domain containing scaffolding protein (Kuchinke, Grawe et al. 1998). The binding of Baz 
to the cell membrane is mediated by direct binding of its C-terminal region to 
phosphoinositide lipids, independently of the PDZ domains (Krahn et al, 2010). Apically 
localized Baz in turn recruits Par-6-aPKC since loss of Baz in neuroblasts results in 
delocalization of Par-6 and aPKC to the cytoplasm (Petronczki and Knoblich, 2001). 
Nonetheless, apical localization of Baz is also, at least partially, dependent on Par6 as 
evident from the mis-localization of Baz in neuroblasts of par-6 mutant (Petronczki and 
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Knoblich, 2001). Acting downstream of Baz, the GTP bound Rho GTPase, Cdc42 (Cell 
division control protein 42) recruits Par-6 to the apical cortex through binding to its 
Cdc42/Rac interactive binding (CRIB) domain (Atwood et al, 2007). In addition, Par-6 
contains a PB1 (Phox and Bem 1) domain, which dimerizes with the PB1 domain of 
aPKC to inhibit its kinase activity (Yamanaka et al; 2001). Binding by Cdc42 in turn 
partially relieves this Par-6 mediated repression of aPKC activity at the apical cortex 
(Atwood et al, 2007). 
aPKC is a serine/threonine kinase that functions as a key regulator of neuroblast 
polarity (Rolls et al, 2003; Lee et al. 2006). It phosphorylates the basal cell fate 
determinants Miranda and Numb to restrict their localization to the basal cortex (Atwood 
and Prehoda, 2009; Smith et al, 2007). The tumor suppressor Lgl (Lethal (2) giant larva) 
is localized uniformly throughout the cell cortex and associates with the Par-6-aPKC 
complex (Betschinger et al, 2003). However, its activity is restricted to the basal cortex 
by inhibitory aPKC-mediated phosphorylation at the apical side (Betschinger et al, 2003). 
Active Lgl at the basal cortex in turn inhibts aPKC, which restricts its activity to the apical 
cortex (Atwood and Prehoda, 2009; Lee et al, 2006). Thus, this ensures phosphorylation 
of Miranda at the apical cortex and its displacement to the basal cortex (Atwood and 
Prehoda, 2009). Functioning upstream of aPKC, the zinc finger transcription factor Zif 
regulates the expression and apical localization of aPKC (Chang et al, 2010). In zif 
mutant, aPKC is uniformly cortical with increasde protein levels, leading to neuroblast 
over-growth (Chang et al, 2010). Conversely, removing a copy of functional aPKC gene 
suppresses neuroblast over-growth phenotype of zif mutant, suggesting that Zif 
functions upstream of aPKC in regulating neuroblast homeostasis (Chang et al, 2010). 
Interestingly, localization and activity of Zif is dependent on aPKC-mediated 
phosphorylation (Chang et al, 2010). Thus, the mutual interplay between Zif and aPKC is 
important for proper aPKC activity in neuroblast. In addition, Dynamin-associated protein 
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160 (Dap160) interacts with aPKC at the apical cortex to regulate its localization and 
kinase activity (Chabu and Doe, 2008).  
Furthermore, aPKC is an important proliferative factor in neuroblasts since loss 
of apkc function results in loss of neuroblasts (Lee et al, 2006). Nonetheless, ectopic 
expression of aPKC does not result in neuroblast over-growth phenotype (Lee et al, 
2006). Instead, ectopic expression of the membrane targeted CAAX prenylated form of 
aPKC (UAS-aPKCCAAX) results in severe neuroblast over-growth (Lee et al, 2006). This 
proliferative function is dependent on its kinase activity since ectopic expression of the 
CAAX prenylated kinase dead form of aPKC does not result in similar brain tumor 
phenotype (Lee et al, 2006). Furthermore, expression of a constitutively active aPKC 
that is predominantly cytosolic (UAS-aPKCΔN) only causes mild neuroblast over-growth, 
suggesting that cortical localization is important for aPKC proliferative function (Lee et al, 
2006). 
 
1.4.2 Mitotic spindle orientation  
With the apical-basal polarity established in neuroblast, mitotic spindle is oriented 
parallel to this axis to ensure proper segregation of apical or basal proteins into different 
daughter cells. Misalignment of the mitotic spindle could result in mis-segregation of the 
apical proliferative proteins into both daughter cells (Chang et al, 2012; Sousa-Nunes 
and Somers, 2013). Such equal inheritance of the proliferative factors causes 
uncontrolled proliferation by both daughter cells leading to brain tumor phenotype 
(Chang et al, 2012; Sousa-Nunes and Somers, 2013). Orientation of the mitotic spindle 
critically relies on an initial centrosomal pathway that assembles the mitotic spindle 
along the apical-basal axis followed by an apical complex mediated spindle-cortex 
interaction that fine tunes the orientation (Sousa-Nunes and Somers, 2013). 
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Centrosomes function as the major microtubule-organizing centers (MTOCs) 
within cells (Gonzalez, 2007). The pair of centrosomes within neuroblast exhibits 
asymmetry and plays important roles in orienting mitotic spindle (Rebeollo et al, 2007; 
Rusan and Peifer, 2007). The larger centrosome that retains its pericentrosomal material 
(PCM) remains fairly immobile at the apical cortex and nucleates numerous astral 
microtubules (Rebeollo et al, 2007; Rusan and Peifer, 2007; Januschke et al, 2011; 
Conduit and Raff, 2010). In contrast, the other centrosome loses its PCM, is smaller and 
highly mobile, moving throughout the cytoplasm to be eventually located at the opposite 
end of neuroblast (Rebeollo et al, 2007; Rusan and Peifer, 2007; Januschke et al, 2011; 
Conduit and Raff, 2010). The larger immobile centrosome is inherited by the self-
renewing neuroblast and is instrumental in specifying the spindle orientation and position 
where apical complexes would be reassembled (Rebeollo et al, 2007; Rusan and Peifer, 
2007; Januschke et al, 2011; Conduit and Raff, 2010). This ensures that the apical-basal 
polarity and spindle orientation are maintained at approximately the same position in 
successive rounds of asymmetric division of neuroblasts. Consistently, transient 
colcemid induced disruption of astral microtubules during interphase results in 
randomized spindle orientation during mitosis (Januschke et al, 2010). However, in 
subsequent rounds of asymmetric division, the apical-basal polarity and spindle axis are 
maintained at the new position (Januschke et al, 2010). Collectively, this result suggests 
that the larger apically located centrosome serves as a reference to direct cortical 
polarity and alignment of spindle to this cortical axis. 
Apart from regulating basal cell fate localization (Atwood and Prehoda, 2009; 
Smith et al, 2007), the Par complex also plays instrumental roles in establishing proper 
spindle orientation (Kuchinke et al, 1998; Petronczki and Knoblich, 2001). Baz recruits 
neuroblast specific adaptor protein Inscuteable (insc) to the apical cortex (Kraut et al, 
1996; Wodarz et al, 1999; Schober et al, 1999). This physical interaction with Insc is 
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necessary to stabilize the apical localization of Baz without affecting its initial recruitment 
to the apical cortex (Wodarz et al, 1999; Schober et al, 1999). In addition, Insc recruits 
the evolutionarily conserved protein complex of Pins (Partner of Inscuteable) and the 
heterotrimeric G protein subunit Gαi (Schaefer, Shevchenko et al. 2000; Yu, Morin et al. 
2000; Schaefer, Petronczki et al. 2001). Pins was first identified as a binding partner of 
Insc in a yeast two-hybrid screen. It is a tetratricopeptide (TPR) domain and GoLoco/GR 
domain protein that associates with the cell cortex and microtubules (Parmentier, Woods 
et al. 2000; Yu, Morin et al. 2000). In insc mutant, Pins-Gαi complex localizes in a 
polarized fashion forming a cortical crescent, however at random positions (Parmentier, 
Woods et al. 2000; Yu, Morin et al. 2000). Like Insc, apical localization of Pins is lost 
upon the loss-of-function of baz (Parmentier, Woods et al. 2000; Yu, Morin et al. 2000). 
Collectively, this evident infers that Insc functions as a linker protein that bridges the Par 
complex with Pins-Gαi complex.  
Pins functions as a guanine-nucleotide dissociation inhibitor (GDI) that binds 
preferentially to the GDP bound form of Gαi (GDP- Gαi) via its GoLoco domain 
(Schaefer et al, 2000; Schaefer et al, 2001). Their apical localizations are mutually 
dependent on each other (Schaefer et al, 2000; Schaefer et al, 2001). The Pins-Gαi 
protein complex is involved in orienting the mitotic spindle along the apical-basal axis in 
a noncanonical pathway independent of G protein coupled receptor (GPCR) signaling 
(Schaefer et al, 2000; Schaefer et al, 2001). Loss of pins or Gαi function results in 
randomized spindle orientation (Schaefer, Shevchenko et al, 2000; Schaefer, Petronczki 
et al, 2001). Pins functions redundantly with another GoLoco/GPR domain protein 
Locomotion defective (Loco) as GDI to regulates Gαi activity (Yu, Wang et al. 2005). 
Both GDIs disrupt the inactive heterotrimeric G protein Gαβγ through direct interaction to 
release GDP-Gαi and Gβγ complexes (Yu, Wang et al. 2005). Unlike Gαi that is apically 
localized, Gβ13F is uniformly cortical and is required to maintain stable localization of 
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apical proteins (Yu et al, 2003). Further, loss-of-function of Gβ13F phenocopies ectopic 
expression of Gαi, suggesting that ectopic expression of Gαi depletes free Gβ13F 
leading to defects in asymmetric division of neuroblast (Yu et al, 2003). In addition, 
Gβ13F also regulates unequal daughter cell size though the exact mechanism of which 
is unknown. The Gαi-Pins-Loco complex functions together with guanine nucleotide 
dissociation exchange factor (GEF), Ric8, to align the mitotic spindle along the apical-
basal axis (Wang et al, 2005, David et al, 2005) 
The Gαi-Pins complex also mediates Mushroom body defective (Mud) 
localization to the apical cortex (Siller, Cabernard et al. 2006; Nipper, Siller et al. 2007). 
Intramolecular interaction between the TPR and GoLoco domains of Pins maintains Pins 
in an inactive “closed” conformation (Nipper, Siller et al. 2007). However, this is 
disrupted by the interaction of GoLoco motifs of Pins with Gαi (Nipper, Siller et al. 2007). 
In turn, Pins could bind through its TPR domain to Mud, thus recruiting Mud to the apical 
cortex (Siller, Cabernard et al. 2006; Nipper, Siller et al. 2007). Mud is the Drosophila 
homolog of the mammalian NuMA (Nuclear mitotic apparatus protein) that regulates 
formation and stability of aster microtubules (Du, Stukenberg et al. 2001). As such, Mud 
is also localized to the spindle poles and mitotic spindles, making it a good candidate 
that link centrosomal asymmetry with the cortical polarity. Indeed, loss-of-function of 
mud results in randomized spindle orientation without affecting apical localization of Gαi-
Pins complex (Bowman, Neumuller et al. 2006; Izumi, Ohta et al. 2006; Siller, Cabernard 
et al. 2006). In addition, the centriolar protein Anastral spindle (Ana2) and dynein light 
chain Cut up (Ctp) co-function to regulate the centrosomal and apical localization of Mud 
independent of the Gαi-Pins complex (Wang, Li et al. 2011). Taken together, Mud 
functions downstream of the Gαi-Pins complex and Ana2-Ctp complex to orient the 
mitotic spindle. Potentially, Mud does so by interacting with the astral microtubules 
emanating from the centrosome. Furthermore, Gαi-Pins complex could regulate mitotic 
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spindle orientation through interacting with the tumor suppressor Discs large (Dlg) and 
plus-end-directed microtubule motor protein Khc73 (kinesin heavy chain 73) (Siegrist 
and Doe 2005). Pins interacts with Dlg via the linker region between the TPR and 
GoLoco domain (Siegrist and Doe 2005). Khc73 in turn binds with the Gαi-Pins-Dlg 
complex via direct interaction with Dlg to regulate its apical localization independent of 
the Par complex (Siegrist and Doe 2005). Taken together, Pins is a critical apical protein 
that regulates mitotic spindle orientation through interacting with either Mud or Dlg.  
 
1.4.3 Asymmetric segregation of basal cell fate determinants  
 Basal cell fate determinants are inherited by the smaller GMC during asymmetric 
division of neuroblast. As mentioned in earlier chapter, phosphorylation of Mira and 
Numb by aPKC restricts their localization to the basal cortex (Atwood and Prehoda, 
2009; Smith et al, 2007). In addition, the movement of the two basal complexes, Mira-
Pros-Brat complex and Numb-Partner of Numb (Pon) complex, occurs at least in part, 
via an actin/myosin cytoskeleton dependent manner mediated by the Drosophila myosin 
II heavy chain (Zipper, Zip), light chain (Spaghetti squash, Sqh) and myosin VI (Jaguar, 
Jar) proteins (Lu et al, 1999, Petritsch et al, 2003, Erben et al, 2008, Barros et al, 2003). 
Loss-of-function of zip, sqh or jar causes mis-localization of basal cell fate determinants. 
Consistently, treatment with the Rho kinase inhibitor Y-27632, which blocks 
phosphorylation of Myosin II, perturbs localization of basal cell fate determinants (Erben 
et al, 2008, Barros et al, 2003). One potential explanation for the observed phenotype is 
that as non-muscle myosin II migrates from the apical cell cortex to the equator and 
eventually the cleavage furrow, cell fate determinants migrate ahead of it resulting in a 
“pushing” action for their basal localization (Erben et al, 2008, Barros et al, 2003). 
However, Y-27362 was shown to inhibit aPKC, which raise concerns on the involvement 
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of the actomyosin pathway in maintaining neuroblast asymmetry (Atwood and Prehoda, 
2009). As such, the actomyosin-mediated basal protein localization remains to be 
proven.  
Mira is a multi-domain adapter that binds and localizes Prospero (Pros), Brain 
tumor (Brat) and Staufen to the basal cortex (Shen et al, 1997; Shen et al, 1998; 
Ikeshima-Kataoka et al, 1997). Protein domain analysis reveals that the asymmetric 
localization domain at the amino terminal of Mira is required for its basal localization 
while its carboxyl cargo binding domain is essential for binding with Pros and Brat 
(Ikeshima-Kataoka et al, 1997; Fuerstenberg et al, 1998; Lee, et al, 2006). Once 
segregated into GMC, Mira is degraded releasing the basal determinants. Consequently, 
loss of mira function results in mis-segregation of basal cell fate determinants in both 
daughter cells and consequently, neuroblast supernumerary (Ikeshima-Kataoka et al, 
1997; Lee, et al, 2006). 
Pros is a homeobox domain transcription factor that was first identified in a 
genetic screen as a regulator of genes expression in GMCs and neurons (Doe et al, 
1991). It is expressed in type I neuroblast where it localizes to the cytoplasm during 
interphase and basal cortex during mitosis (Hirata et al, 1995; Knoblich et al, 1995; 
Spana and Doe, 1995). While Pros does not regulate gene expression within 
neuroblasts due to its cytoplasmic localization, it was however shown that high level of 
Pros can results in its translocation into the nucleus causing premature differentiation of 
neuroblast (Choksi et al, 2006; Cabernard and Doe, 2009; Bayraktar et al, 2010). 
Regulation of the sub-cellular localization of Pros remains elusive though recently the 
Ran GTPase guanine-nucleotide exchange factor (GEF) Bj1 was implicated to regulate 
nuclear export of Pros in neuroblasts (Joy et al, 2104). In GMC, Pros translocates into 
the nucleus where it represses self-renewal genes, such as stem cell markers and cell 
cycling genes, and also activates expression of genes required for differentiation (Choksi 
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et al, 2006). Therefore, loss-of-function of pros results in altered gene expression in 
GMCs causing the adoption of neuroblast fate, which leads to the formation of larval 
brain tumor (Doe et al, 1991; Choksi et al, 2006; Lee et al, 2006; Betschinger et al, 
2006). 
Apart from the asymmetric localization of Pros, mRNA of Pros is likewise 
localized asymmetrically to the basal cortex during neuroblast division (Li et al, 1997; 
Broadus et al, 1998). Pros mRNA is apically localized during interphase but is later re-
located to the basal cortex at late prophase (Li et al, 1997). The RNA binding protein 
Staufen and Insc effect this re-localization of Pros mRNA as evident from the 
observation that Pros mRNA remains apically localized in insc or stau mutant 
neuroblasts (Li et al, 1997; Broadus et al, 1998). Though loss of Pros mRNA asymmetry 
alone is insufficient to disrupt cell fate of GMCs, asymmetric segregation of Pros mRNA 
into GMCs is important since pros gene is not transcribed in GMC (Broadus et al, 1998).  
 Brat belongs to a family of evolutionarily conserved tumor suppressor proteins, 
the TRIM (tripartite motif)-NHL (NCL-1, HT2A and LIN-41) protein family (Arama et al, 
2000). It is a translational repressor that functions as a growth regulator in neuroblast 
development, particularly in the GMCs (Lee et a, 2006; Betschinger et al, 2006; Bello et 
al, 2006). In neuroblasts of brat mutant, basal localization of Pros is lost and neuroblasts 
undergo un-controlled proliferation leading to brain tumor phenotype (Lee et al, 2006; 
Betschinger et al, 2006; Bello et al, 2006). In addition, total level of Pros in brat mutant 
brains is significantly reduced and ectopic expression of Pros in brat mutant neuroblast 
clones could suppress neuroblast over-growth (Bello et al, 2006). Likewise, Brat level is 
reduced in pros mutant suggesting their co-dependence on each other for their 
expression (Lee et a, 2006; Betschinger et al, 2006). Together, this evidence suggests 
that Brat functions upstream of Pros to regulate its localization into GMCs, though the 
exact mechanism is unknown. Further, Brat was also shown to inhibit dMyc, which is an 
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important regulator of cell growth and cell cycle progression (Betschinger et al, 2006). 
Brat down-regulates dMyc post-transcriptionally in GMCs to inhibit protein synthesis and 
cell growth and thereby suppresses proliferation (Betschinger et al, 2006). Nonetheless, 
it is uncertain whether Brat regulates dMyc translation, protein or mRNA stability to effect 
down-regulation of dMyc in GMCs. 
 Numb is a PTB (phosphotyrosine-binding) domain protein that antagonizes Notch 
signaling through binding with the NICD to promote its endocytosis. (Skeath and Doe, 
1998). It was first identified as a cell fate regulator in the Drosophila sensory organ 
precursor (SOP) cells, where it is asymmetrically inherited by one of the daughter cells 
(Uemura et al, 1989). Likewise, GMCs divide asymmetrically such that Numb is inherited 
only by one of the daughter cells. In the Numb positive daughter cell, Notch signaling is 
inhibited, which is in contrast to the active Notch signaling in the Numb negative 
daughter cell, providing the basis for binary fate decision (Knoblich et al, 1995; 
Cayouette and Raff, 2002). Thus, Notch/Numb signaling functions in GMCs as binary 
fate decision machinery to diversify the fate of daughter cells generated upon post-
mitotic division of GMCs (Knoblich et al, 1995; Cayouette and Raff, 2002). In addition, 
Numb functions as a tumor suppressor in neuroblasts, potentially through inhibiting 
Notch signaling in the GMC to suppress stem cell fate (Wang et al, 2006). Consequently, 
loss-of-function of numb results in neuroblast supernumerary possibly through ectopic 
Notch signaling in the GMCs causing un-controlled proliferation (Wang et al, 2006; 
Bowman et al, 2008). Consistently, ectopic expression of NICD in neuroblasts results in 
neuroblast over-growth phenotype, which supports the notion that the tumor suppression 
function of Numb relies on its antagonistic function on Notch signaling (Wang et al, 
2006). 
 Apart from the aPKC-mediated phosphorylation of Numb to regulate its 
asymmetric localization, the adapter protein Pon is also instrumental in controlling basal 
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localization of Numb (Smith et al, 2007; Wang et al, 2007).  Pon was identified in a 
yeast-two-hybrid screen as a physically interactor of Numb. It functions to regulate 
asymmetric localization of Numb in muscle progenitors and loss of pon function disrupts 
this asymmetry. Similarly, loss of pon causes uniform cortical expression of Numb in 
neuroblasts at metaphase, though this phenotype is rescued at telophase (Lu et al, 
1998).  The Pon-mediated regulation of Numb localization in neuroblasts can be further 
modulated by the Polo kinase (Wang et al, 2007). Polo phosphorylates Pon at serine 
residue 611 to induce its polarized localization and thus asymmetrical localization of 
Numb (Wang et al, 2007).  
 
1.5 Regulation of asymmetric cell division by cell cycle regulators 
 Asymmetric cell division is temporally coordinated with cell cycling (Souse-Nunes 
and Somers, 2013). At prophase, the Par complex localizes to the apical cortex, driving 
the basal localization of cell fate determinants. Such asymmetric localization continues 
through metaphase and eventually to telophase to ensure the asymmetric inheritance of 
proliferation factors like aPKC by the self-renewing neuroblast and differentiation factors 
such as Pros, Brat and Numb by GMC (Sousa-Nunes and Somers, 2013). Coordination 
between asymmetry and cell cycling relies on the activity of various mitotic kinases and 
phosphatases. 
 Aurora-A (AurA) kinase is activated at the onset of mitosis and was 
demonstrated to be important for the basal localization of Numb (Berdnik and Knoblich, 
2002; Lee et al, 2006b; Wang et al, 2006). Active AurA phosphorylates Par6 at Ser34 in 
the PB1 domain (Wirtz-Peitz et al, 2008). This in turn initiates auto-phosphorylation of 
aPKC, which causes it to become active and phosphorylates Lgl (Wirtz-Peitz et al, 
2008). Phosphorylated Lgl loses its ability to bind to the cytoskeleton and detaches from 
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the Par6-aPKC complex allowing Baz to associate with the complex instead (Wirtz-Peitz 
et al, 2008). This forms the active Par complex at the apical cortex during late interphase 
that phosphorylates Mira and Numb leading to their basal localization (Wirtz-Peitz et al, 
2008; Smith et al, 2007). Furthermore, apical localization of Mud is perturbed leading to 
uniform cortical expression in aurA mutant neuroblasts. This suggests that AurA not only 
regulates aPKC activity to control asymmetric protein localization, it also likely regulates 
mitotic spindle orientation (Wang et al, 2006; Lee et al, 2006).  
 A second mitotic kinase that is involved in regulating asymmetric division of 
neuroblast is Polo kinase (Llamazares et al, 1991; Wang et al, 2007). Polo 
phosphorylates Pon at Ser611 leading to its basal localization (Wang et al, 2007). As 
such, phosphorylation of Pon in turn ensures basal localization of Numb and its proper 
segregation into the GMC (Wang et al, 2007). Moreover, Polo also regulates apical 
localization of aPKC and mitotic spindle orientation to ensure proper asymmetric division 
of neuroblasts (Wang et al, 2007). 
 With the regulatory roles that mitotic kinases play in asymmetric division of 
neuroblasts, it is no surprise that dephosphorylation to appropriate extent also plays 
important regulatory functions. However, contrary to the observed neuroblast over-
growth phenotype of aurA or polo mutants, loss-of-function of the Protein Phosphatase 
2A (PP2A) likewise results in brain tumor phenotype (Wang et al, 2009; Chabu and Doe, 
2009). PP2A is a serine/threonine phosphatase comprising of a catalytic subunit, a 
scaffolding subunit and one of the variable regulatory subunits Twins (Tws), Widerborst 
(Wdb), B56-1 or PR-72 (Sontag, 2001; Snaith et al, 1996; Mayer-Jaekel et al, 1992; 
Shiomi et al, 1994; Uemura et al, 1993; Hannus et al, 2002. Microtubule star (Mts), the 
catalytic subunit of Protein Phosphatase 2A (PP2A) physically associates with Par6 and 
dephosphorylates AurA-phosphorylated Ser34 with consequential inhibition of aPKC 
activity (Ogawa et al, 2009). In addition, PP2A complex also dephosphorylates Baz at 
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Ser1085 to regulate its apical localization (Krahn et al, 2009). Moreover, Tws physically 
associates with aPKC to aid in its exclusion from the basal cortex (Chabu and Doe, 
2009; Ogawa et al, 2009).  As such, loss of PP2A activity results in delocalization of 
aPKC, Pon and Numb, spindle mis-orientation with consequential neuroblast over-
growth phenotype (Wang et al, 2009; Chabu and Doe, 2009; Krahn et al, 2009; Ogawa 
et al, 2009). Other than the indirect regulation of Pon-Numb complex through regulating 
aPKC activity, PP2A was also demonstrated to regulate phosphorylation of Numb in a 
Polo dependent manner (Wang et al, 2009). PP2A regulates the expression of Polo in 
neuroblasts. Upon loss of PP2A activity, transcript level and protein abundance of Polo 
are dramatically reduced. Over-expression of Polo or Numb could suppress neuroblast 
supernumerary phenotype of PP2A mutant (Wang et al, 2009). More recently, PP2A was 
demonstrated to directly dephosphorylate Numb to regulate its function (Ouyang et al, 
2011). Collectively, this body of evidence suggests that PP2A functions in the Polo-
Numb pathway to regulate asymmetric division of neuroblasts (Wang et al, 2009). 
 A second phosphatase that similarly regulates asymmetric division of 
neuroblasts is Protein Phosphatase 4 (PP4) (Sousa-Nunes et al, 2008). The regulatory 
subunit of PP4, Falafel (Flfl) localizes predominantly in the nucleus during interphase 
and becomes cytoplasmic upon nuclear envelope breakdown (Sousa-Nunes et al, 
2008). Flfl physically associates with Mira and cytoplasmic or membrane Flfl is required 
for asymmetric localization of Mira and its cargo proteins Pros, Brat and Stau during 
mitosis (Sousa-Nunes et al, 2008). Additionally, nuclear localized Flfl is important for 
nuclear exclusion of Mira and Pros during interphase (Sousa-Nunes et al, 2008). As 
such, in flfl mutant, basal cell fate determinants are delocalized to the cytoplasm in 
mitotic neuroblasts whereas Pros and Mira become nuclear localized in interphase 
neuroblasts (Sousa-Nunes et al, 2008). Given these observations, it is likely that Flfl 
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targets PP4 to Mira for dephosphorylation, which is important for its basal localization 
and segregation into the GMCs (Sousa-Nunes et al, 2008).  
 
1.6 Neuroblast lineages in Drosophila central brain 
 Larval brain is an extensively used model to understand development and 
lineage progression of neuroblasts (Homem and Knoblich, 2012). It is composed of two 
brain hemispheres and a ventral nerve cord (Fig. 4). Each brain hemisphere is 
comprised of the central brain region and the optic lobe that develops into the central 
processing module of adult fly visual system (Fig. 4; Apitz and Salecker, 2014). There 
are four types of neuroblast lineages in the larval brain hemisphere, namely the type I 
and II lineages in the central brain, mushroom body neuroblasts and optic lobe 
neuroblasts (Homem et al, 2012). In the central brain, there are approximately 100 
neuroblasts, of which approximately 90 are type I neuroblasts and 8 are type II 
neuroblasts (Homem and Knoblich, 2012; Change et al, 2012; Bello et al, 2008; Boone 
and Doe, 2008; Bowman et al, 2008). The two types of neuroblast lineages can be 
distinguished by differential cell fate markers expression, their anatomical locations and 
types of immediate progeny generated (Bello et al, 2008; Boone and Doe, 2008; 
Bowman et al, 2008). Type I neuroblasts are located in both anterior and posterior sides 
of the brain hemisphere (Boone and Doe, 2008). It can be identified by the their nuclear 
expression of the basic helix-loop-helix (bHLH) proneural transcription factor, Asense 
(Ase) (Brand et al, 1993) and the bHLH pan-neural transcription factor Deadpan (Dpn) 
(Bier et al, 1992), and cytoplasmic expression of the homeobox domain transcription 
factor Prospero (Pros) (Boone and Doe, 2008). With each asymmetric division, type I 
neuroblast self-renews and at the same time generates a GMC that expresses nuclear 
Ase and Pros (Weng and Lee, 2011; Sousa-Nunes and Somers, 2014).  
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Type II neuroblasts on the other hand, are located on the posterior sides of the 
brain hemisphere with six lineages residing at the dorso-medial region and two at the 
dorso-lateral region (Bello et al, 2008; Boone and Doe, 2008; Bowman et al, 2008). 
Unlike type I neuroblasts, type II neuroblasts only express nuclear Dpn and generate a 
daughter cell known as the intermediate neural progenitor  (INP) (Fig. 4; Bello et al, 
2008; Boone and Doe, 2008; Bowman et al, 2008). The newly formed INP undergoes a 
maturation process, which can be characterized by the gain of Ase expression, going 
from the Ase negative immature form to the Ase expressing immature stage (Fig. 4; 
Bowman et al, 2008; Weng and Lee, 2011). In its fully matured form, INP expresses 
nuclear Dpn and Ase, and cytoplasmic Pros (Bello et al, 2008; Boone and Doe, 2008; 
Bowman et al, 2008). Mature INPs possess restricted proliferative ability and will 
undergo approximately 8-10 rounds of asymmetric division to self-renew and generate 
GMCs (Fig. 4; Weng et al, 2010). As such, INPs make up a population of transit 
amplifying cell in type II lineages, allowing the generation of a larger neuronal 
population. Collectively, type II lineages generate more than 5000 neurons that populate 
the central complex and other major neuropiles in the adult brain (Bayraktar et al, 2010; 
Izergina et al, 2009). In this aspect of progeny amplification, INPs in the type II lineages 





Fig. 3: Type I and II neuroblast lineages in Drosophila larval brain. Larval brain is 
composed of two brain hemispheres and a ventral nerve cord (VNC). Each brain 
hemisphere contains an optic lobe region that develops into the adult fly visual system 
and a central brain region where type I and II neuroblasts lineages reside. Type I 
neuroblasts undergo asymmetric division to self-renew and to generate a smaller 
daughter cell known as ganglion mother cell (GMC) that differentiate and undergo a 
terminal division to form two neurons/glia. On the other hand, with each asymmetric 
division, type II neuroblasts self-renew and generate a daughter cell called the 
intermediate neural progenitor (INP). Newly formed INPs are immature and will undergo 
a maturation process characterized by the gain of Asense (Ase). In the mature form, 
INPs possess limited proliferative ability and can undergo 8-10 rounds of asymmetric 
division to self-renew and generate GMCs that give rise to neurons/glia. Consequently, 






1.6.1 Development of type II neuroblast lineages  
 During stem cell development, establishment of an increasingly restricted 
developmental potential is of importance to ensure unidirectional progression. Notch 
signaling is one of the major regulators implicated in the unidirectional development of 
type II neuroblast lineages (Weng et al, 2010; Weng and Lee, 2011). It promotes cell 
growth and de-differentiation of INP back into neuroblast fate and active mechanisms 
are required to suppress its activity to ensure normal differentiation (San-Juan and 
Baonza, 2011; Zacharioudaki et al, 2012). While loss of Notch signaling results in loss of 
neuroblasts, Notch hyperactivity results in severe neuroblast over-growth phenotype 
(Song and Lu, 2011). It was proprosed that up-regulation of elongation factor 4E (eIF4E) 
and dMyc contribute to the over-growth phenotype of Notch hyperactivity (Song and Lu, 
2011). Knock down of eIF4E or dMyc efficiently suppresses Notch induced brain tumor 
(Song and Lu, 2011). Common to both neuroblast lineages, stem cell determinants Dpn 
and zinc finger transcription factor Klumpfuss (Klu) confer “stemness” to the neuroblasts 
(San-Juan and Baonza, 2011; Berger et al, 2012; Xiao et al, 2012) and likely function 
downstream of Notch signaling. Consistently, loss-of-function of dpn or klu causes loss 
of neuroblast potentially due to premature differentiation (San-Juan and Baonza, 2011; 
Berger et al, 2012; Xiao et al, 2012). Ectopic expression of Klu or Dpn in type II lineages 
results in neuroblast over-growth, whereas ectopic expression of either proteins in type I 
has no effect on neuroblast proliferation (Berger et al, 2012; Xiao et al, 2012). 
Collectively, this evidence suggests that Dpn and Klu function as competence factors in 
type II neuroblast lineages. However, ectopic expression of Klu in notch mutant clone 
only rescues premature loss of neuroblast but does not result in neuroblast over-growth 
(Xiao et al, 2012). Further, loss of klu only partially suppresses neuroblast over-growth 
induced by Notch hyperactivity (Xiao et al, 2012). These suggest that Klu is one of the 
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several downstream effectors of Notch signaling. dpn on the other hand is not able to 
suppress neuroblast over-growth induced by Notch hyperactivity even though it is a 
direct downstream target of Notch signaling, possibly due to functional redundancy with 
other bHLH transcription factor (San-Juan and Baonza, 2011; Zacharioudaki et al, 
2012).  
 
Fig. 4: Development of type II neuroblast lineages. Homeodomain transcription factor 
PointedP1 (PntP1) is expressed in neuroblast and immature INPs while zinc finger 
transcription factor Earmuff (Erm) is expressed only in immature INPs. Within type II 
neuroblast, PntP1 suppresses Ase expression, which is a pre-requisite for INP 
generation. Erm suppresses de-differentiation of INP by suppressing Notch activity and 
induces differentiation through positive regulation of Pros expression. Numb functions 
primarily through suppressing Notch pathway. Brain tumor (Brat) regulates expression 
and localization of Adenomatous polyposis coli 2 (APC2), which in turn inhibits Armadillo 
(Arm) dependent gene expression. Consequently, Brat regulates responsiveness to 






Unique to type II neuroblasts, the homeobox domain transcription factor 
pointedP1 (PntP1) suppresses Ase expression, which is a pre-requisite for INP 
generation (Fig. 5; Zhu et al, 2011). Forced expression of PntP1 in type I lineages 
results in type I to type II transformation with the ability to generate INPs (Zhu et al, 
2011). Though ectopic expression of Ase in type II lineages prevents INP formation, 
suppression of Ase expression in type I lineages fails to generate INPs (Zhu et al, 2011). 
Collectively, this evidence suggests that Ase alone is insufficient to induce the different 
neuroblast fates. In addition, PntP1 is also expressed in immature INPs; however its 
function within these cells reis unknown.  
Earmuff (Erm) is another type II lineage specific regulator (Weng et al, 2010). It is 
a zinc finger transcription factor that is specifically expressed in INPs within type II 
lineages (Weng, et al, 2010). Loss of erm function results in type II specific neuroblast 
over-growth phenotype with the observation that sub-clones can be formed from primary 
neuroblast clones of erm mutant (Weng et al, 2010). This type II specific neuroblast 
over-growth can be partially suppressed by the loss of Notch activity (Fig. 5; Weng et al, 
2010). In addition, Pros transcript level is reduced in larval brain of erm mutant, 
suggesting that Erm promotes Pros expression to induce differentiation (Fig. 5; Weng et 
al, 2010). Together, this evidence implies that Erm suppresses de-differentiation of INP 
by inhibiting Notch signaling and promoting differentiation (Weng et al, 2010). 
Similar to the mammalian transit amplifying cells, Drosophila INPs undergo 
maturation, which involves the parallel function of the basally segregated Brat and Numb 
(Bowman et al, 2008). Through inducing endocytosis of Notch receptor, Numb 
antagonizes Notch activity to prevent de-differentiation of the immature INPs (Fig. 5; 
Bowman et al, 2008). Similar to loss-of-function of Numb, a population consisting of type 
II neuroblasts and immature INPs but not mature INPs is observed in the type II lineages 
of brat mutant (Bowman et al, 2008). Despite this similarity in phenotype of brat and 
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numb mutants, it is unlikely that Brat acts upon Notch signaling since ectopic expression 
of Brat does not suppress Notch activity (Bowman et al, 2008). Nonetheless, like Notch 
hyperactivity, neuroblast over-growth in brat mutant proceeds via a Klu-mediated 
mechanism in a Notch independent manner (Fig. 5; Xiao et al, 2012). Further, Brat 
functions independent of its NHL domain and thus of its translation repressor function 
(Komori et al, 2014). Rather, Brat mediated INP maturation also involves the Wnt 
signaling pathway (Komori et al, 2014). Loss-of-function of Adenomatous polyposis coli 
2 (Apc2) enhances neuroblast over-growth of brat (Komori et al, 2014). Further, 
expression and cortical localization of Apc2 is significantly reduced in type II neuroblasts 
in brat mutant (Komori et al, 2014). Consistently, ectopic expression of Armadillo (Arm), 
which is the substrate of Apc2/Axin/Gsk3β/CKI destruction complex, similarly enhances 
neuroblast over-growth phenotype in brat mutant (Komori et al, 2014).  Together, this 
evidence suggests that Brat suppresses Arm dependent transcription by regulating 
expression and sub-cellular localization of Apc2 (Fig. 5). Furthermore, ectopic 
expression of Klu in arm mutant background results in significantly weaker over-growth 
phenotype than ectopic expression of Klu in wild type background (Komori et al, 2014). 
However, ectopic expression of Arm or loss of apc2 in wild type background fails to 
induce neuroblast supernumerary (Komori et al, 2014). Collectively, this body of 
evidence infers that Wnt signaling functions downstream of Brat to regulate 










1.7 Neuroblast temporal identity contributes to neuronal diversity  
Embryonic neuroblasts in the VNC undergo a series of asymmetric divisions to 
generate neurons of distinct fates in a stereotypic temporal pattern. Delaminated 
neuroblasts sequentially express a series of temporal transcription factors starting with 
Hunchback (Hb), followed by Seven up (Svp), Kruppel (Kr), then Pdm1/Pdm2 (Pdm) and 
ending with Castor (Cas) (Fig. 2; Brody et al, 2000; Grosskortenhaus et al, 2005; Isshiki 
et al, 2001; Kambadur et al, 1998). Though feedback and feed-forward loops exist 
between the temporal factors to regulate their expression, the precise mechanism that 
regulates the switch from one temporal factor to the next remains elusive 
(Grosskortenhaus et al, 2005). It was postulated that progression from Hb expression to 
Kr expression is cell cycle dependent, occurring after a specific number of neuroblast 
divisions (Grosskortenhaus et al, 2005). On the contrary, subsequent temporal factor 
transitions are cell cycle independent and likely involve a neruoblast intrinsic timer. 
However, the exact molecular mechanism of these transitions is still unknown 
(Grosskortenhaus et al, 2005; Homem and Knoblich, 2012).  Expression of the temporal 
transcription factor of the primary neuroblasts is retained in GMCs and neurons (Fig. 2; 
Isshiki et al, 2001; Grosskortenhaus et al, 2005). These temporal factors together with 
spatial cues including Hox genes, dorsal-ventral patterning genes and segmentation 
genes confer GMCs and thus neurons with unique identity, contributing to neuronal 
diversity (Hartenstein and Wodarz, 2014; Murange et al, 2012). Interestingly, temporal 
cascade continues in the larval stage, where the post-embryonic neuroblasts in thoracic 
VNC retain Cas expression followed by subsequent switch to Seven-up (Svp) 
expression (Fig. 2; Maurange et al, 2008). However, it is uncertain if additional temporal 
factors exist after Svp expression and whether this temporal cascade is similarly 
employed in the central brain neuroblasts. Cas and Svp expression in postembryonic 
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neuroblasts regulate the switch from early born, large Chinmo expressing neurons to the 
smaller size Broad complex (Br-C) expressing neurons at second instar larval stage 
(Maurange et al, 2008).  
Apart from contributing to diverse neuron identities, these neuroblast temporal 
factors and their downstream target Grh also play critical role in regulating the 
permanent exit from proliferation before adulthood (Sousa-Nunes and Somers, 2013; 
Homem and Knoblich, 2012; Maurange et al, 2008). In the abdominal segments of VNC, 
neuroblasts undergo apoptosis through the function of pro-apoptotic proteins Reaper, 
Hid and/or Grim (Bello et al, 2003; Peterson et al, 2002). Activation of these pro-
apoptotic proteins requires co-expression of Abdominal-A (AbdA) Hox/homeotic protein 
and the downstream effector of temporal cascade, Grainyhead (Grh) transcription factor 
in neuroblasts (Almeida and Bray, 2005; Cenci and Gould, 2005; Maurange et al, 2008). 
In the thoracic neuroblasts however, Cas induces Grh expression that in turn 
suppresses premature nuclear Prospero (Pros) at early larval stages (Maurange et al, 
2008).  Whereas Svp expression at later stage induces a transient burst of nuclear Pros 
expression at pupal stage that initiates timely exit from neuroblast proliferation 
(Maurange et al, 2008). In the abdominal segments of embryonic VNC, most neuroblasts 
remain proliferative till the end of embryonic stage and would only undergo apoptosis at 
the end of larval stage (Bray et al, 1989; White et al, 1994; Maurange et al, 2008). As 
evident, the decision between apoptosis and quiescence is regulated by the temporal 
factors and spatial cues (Tsuji et al, 2008).  Nonetheless, the four Mushroom Body 
neuroblasts are exempted from quiescent and apoptosis at the end of embryonic stage. 
They continue to proliferate through to post-embryonic stages to generate the neuropile 
involves in olfactory learning and memory (Prokop and Technau, 1991; Ito and Hotta, 
1992). Nonetheless, mushroom body neuroblasts likewise permenantly exit from cell 
cycling though the mechanism is unknown. 
33 
 
Fig. 5: Temporal regulation of neuroblasts. (A) Temporal patterning of VNC 
neuroblasts. A series of transcription factors regulates the identity of neuroblasts and 
their neural progenies. NBs express different transcription factors at different temporal 
points that are inherited by the GMC and neurons. Embryonic NBs consecutively 
express Hunchback (HB, yellow), Seven up (Svp, orange), Kruppel (Kr, blue), Pdm1/2 
(Pdm, red) and lastly, Castor (Cas, green) before entering quiescence. At larval stage, 
NBs resume Cas expression but transit to Svp expression shortly after. However, 
temporal transcription factors express after Svp in larval and pupal stage have not been 
identified. (B) Temporal patterning of DM2-3 type II neuroblasts. DM1-3 type II 
neuroblasts express Diachete (D) and Castor (cas) at 24 hrs after larval hatching (ALH), 
Svp is transiently expressed at 48 hrs ALH. Temporal factor expresses at later stage is 
unknown. In addition, INPs generated from DM2-6 type II neuroblasts also exhibit 
temporal patterning. INPs sequentially express of D, Grainyhead (Grh) and Eyeless (Ey) 
over time. Ey+ old INPs generated from early D+/Cas+ neuroblasts produce either Repo+ 
(Reverse polarity) glia or Toy+ (Twin of eyeless) neurons. Late neuroblasts derived D+ 
young INPs produce D+ or Bsh+ (Brain-specific homeobox) progenies.  
 
On the contrary, it is unknown whether the temporal cascade that operates in the 
embryonic VNC functions similarly in the central brain neuroblasts, which originate from 
the procephalic neuroectoderm. Nonetheless, these neuroblasts can be individually 
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identified based on their differential expression of 40 molecular markers (Sprecher et al, 
2007; Urbach and Technau, 2003). This suggests that central brain neuroblasts do 
acquire unique identity much like the embryonic VNC neuroblasts, though the 
mechanism of which is less understood. More recently, it was demonstrated that three 
type II neuroblasts residing at the anterior-most dorsomedial (DM) region of the central 
brain (probably DM1-3) sequentially express three candidate temporal identity factors 
over time (Bayraktar and Doe, 2013). These neuroblasts express Diachete (D) and Cas 
at 24hrs after larvae hatching (ALH) while Svp is transiently expressed at 48 hrs ALH 
(Bayraktar and Doe, 2013). However, temporal factor expresses at later time point has 
not been identified. Further, INPs generated by DM2-6 type II neuroblasts also exhibit 
temporal patterning via sequential expression of D, followed by Grainyhead (Grh) and 
lastly Eyeless (Ey) (Bayraktar and Doe, 2013). These candidate temporal factors 
express in INPs regulate each other’s expression forming a feedforward activation or 
feedback repression mode of cross-regulation (Bayraktar and Doe, 2013). In addition, 
the D expressing young INPs generate progenies that express D or Brain-specific 
homeobox (Bsh) while Ey expressing old INPs produce either Reverse Polarity (Repo) 
positive glia or Twin of eyeless (Toy) positive neurons (Bayraktar and Doe, 2013). 
Together, temporal patterning of neuroblasts and INPs could diversify neuronal 
population in the adult brain. However, this only account for a sub-population of neurons 
and additional yet-identified temporal factors might exist. Moreover, Ey functions to 
ensure timely exit of INPs from cell cycle (Bayraktar and Doe, 2013). Loss of ey results 
in an expanded population of INPs that occurs due to failure to exit cell cycle (Bayraktar 
and Doe, 2013). On the other hand, cell cycle exit of central brain neuroblasts is 
independent of temporal identity factors. It was recently shown that Ecdysone signaling 
and Mediator complex co-function to regulate the expression of metabolic enzymes to 
increase oxidative phosphorylation in neuroblasts at pupal stage (Homem et al, 2014). 
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As a result, neuroblasts in the central brain progressively shrink in size, transiently 
express Pros, which regulates Dacapo (Dap) expression and undergo terminal 
differentiation at approximately 24 hours after pupa formation (APF) (Homem et al, 2014; 
Colonques et al, 2011).  
 
1.8 Epigenetic regulations in Drosophila  
1.8.1 Brahma (Brm) chromatin remodeling complex 
Within the nucleus, DNA interacts with proteins known as histone to form a DNA-
protein complex with extensive coiling called chromatin (Trotter and Archer, 2008; 
Halliday et al, 2009; Mohrmann and Verrijzer, 2004). Access to DNA for replication, 
transcription and DNA repair requires re-structuring of the chromatin (Trotter and Archer, 
2008; Halliday et al, 2009). One category of regulators is the chromatin remodeling 
complexes (Trotter and Archer, 2008; Halliday et al, 2009). These complexes use 
energy from ATP hydrolysis to weaken DNA-histone interaction that in turn allows 
remodeling of the chromatin structure (Johnson et al, 2005). Such remodeling facilitates 
binding of transcription factors to specific sites to activate or repress gene expression 
depending on the activity of the bound transcription factors (Trotter and Archer, 2008). 
There are four major classes of chromatin remodelers, namely the Switch/Sucrose Non-
fermentable (SWI/SNF), imitation switch (ISWI), Mi-2/NuRD (nucleosome remodeling 
deacetylase) and Ino80 complex that are classified based upon their ATPase subunits 
(Fig. 6; Mohrmann and Verrijzer, 2004). Among these classes of chromatin remodelers, 
SWI/SNF is the most extensively studied and is evolutionarily conserved (Halliday et al, 
2009; Mohrmann and Verrijzer, 2004). 
Components of the SWI/SNF complex are originally discovered in yeast through 
two independent screens that identified regulators of either the mating-type switching 
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(SWI) or sucrose non-fermenting phenotype (Reisman et al, 2009; Mohrmann and 
Verrijzer, 2004; Carlson et al, 1981; Neigeborn and Calrson, 1984; Stern et al, 1984; 
Abrams et al, 1986; Nasmyth and Shore, 1987; Carlson and Laurent, 1994). Whereas 
SWI/SNF is relatively rare in the yeast, regulating approximately 5% of all yeast genes, 
the Drosophila SWI/SNF complex, also known as Brahma (Brm) remodeling complex, is 
estimated to regulate 1-2% of genes to almost the entire Drosophila genome (Reisman 
et al, 2009; Armstrong et al, 2002; Sudarsanam et al, 2000).  
Drosophila Brm remodeling complex is a large multimeric complex, which 
comprises of 8 to 11 components (Fig. 6; Mohrmann and Verrifzer, 2005; Marenda et al, 
2004). The core complex of Brm remodeler contains 6 components including Brm, Brm 
associated protein (Bap) 60kDa (Bap60), Bap55, Moira, Dalao and Snf5-related 1 (Snr1) 
(Fig. 6; Mohrmann and Verrijzer, 2004). Brm is the ATPase subunit of the Brm 
remodeling complex (Reisman et al, 2009). It is a member of the Drosophila trithorax 
gene groups that functions as dominant suppressor of polycomb mutations and also 
activator of Hox genes involved in body segmentation (Reisman et al, 2009; Tamkun et 
al, 1992; Tamkun, 1995; Papoulas et al, 1998; Armstrong et al, 2002). Brm contains an 
ATPase domain that comprises of an amino-terminal DEXD and a C-terminal helicase C 
domain (Fig. 6; Mohrmann and Verrijzer, 2004). In addition, Brm also contains a 
bromodomain involves in recognizing acetylated histone lysine residues or protein–
protein interaction (Fig. 6; Mohrmann and Verrijzer, 2004). In vitro analysis revealed that 
Brm alone possesses basal ATPase activity sufficient for chromatin remodeling function. 
(Laurent et al, 1993; Muchardt and Yaniv, 1993; Phelan et al, 1999). In contrast, other 
components of Brm core complex are postulated to play structural roles in maintaining 
stability of the multimeric complex and interaction with DNA or to provide target 
specificity (Neely et al, 2002).  
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Brm complex can be further divided into two sub-complexes; the BAP (Brahma 
associated protein complex) or polybromo-BAP (PBAP) complexes, depending upon the 
presence of the AT-rich DNA interacting domain (ARID)-containing Osa or the 
polybromo domain-contain Bap180 (Fig. 6; Biegel et al, 2014; Reisman et al, 2009; 
Trotter and Archer, 2008). These complexes exhibit distinct and overlapping genome 
distribution and function either synergistically or antagonistically in different cell types 
(Mohrmann et al, 2004; Reisman et al, 2009). Despite the different functions of the two 
sub-complexes, Brm is mainly found localized at open, hyper-acetylated chromatin and 
thus marks almost all transcriptionally active chromatin (Armstrong et al, 2002).  
Depending upon which sub-complexes and configuration of the associating co-
factors, Brm complex could regulate a repertoire of cellular processes including cell 
growth, proliferation, apoptosis, cell cycling, cellular differentiation and genomic stability 
(Trotter and Archer, 2008; Reisman et al, 2009). Brm complex is extensively involved in 
the development of Drosophila, ranging from body segmentation, imaginal disc and 
muscle organ development to hemocyte proliferation, adult fly intestinal stem cell 
proliferation and cell fate commitment, dendrite morphogenesis and pruning (Tamkun, 
1995; Marenda et al, 2003; Parrish et al, 2006; Chalkley et al, 2008; Terriente-Félix and 
de Celis, 2009; Kirilly et al, 2011; Curtis et al, 2011; Tea and Luo, 2011; Zeng et al, 
2013; Jin et al, 2013). More recently, Brm, Mor and Osa are identified in a genome wide 
transgenic RNAi screen as regulators of neuroblast homeostasis (Neumuller et al, 2011), 






Fig. 6: Chromatin remodeling complexes in Drosophila. (A) Domains found in 
ATPase subunit of the 4 major classes of chromatin remodeling complex. Each contains 
a distinct ATPase domain containing signature structural domains. ATPase domain of 
Brm contains a DEXD and HELIC domain at the amino and carboxyl terminal 
respectively. In addition, Brm contains a Bromo domain; ISWI contains SANT (SWI3, 
ADA2, N-CoR and TFIIIB) and SLIDE (SANT-like ISWI domain) while dMi-2 contains 
PHF and Chromo. INO80 contains an extended ATPase domain. (B) Four major classes 
of chromatin remodeling complex. Drosophila SWI/SNF complex could occur as 
polybromo-containing Polybromo Brahma Associated Protein (PBAP) complex or Osa-
containing BAP complex. INO80 complex is composed of RVB1/2, Arp5/8 and several 
other components. ISWI complex could exist as ACF, NURF or CHRAC complex while 




1.8.2 Histone modification by Histone Deacetylase (HDAC) 
The second group of epigenetic regulators is histone modifiers (Grant, 2001; 
Bannister and Kouzarides, 2011). These are enzymes that catalyze the post-
translational covalent modifications of histone tails through the addition or removal of 
molecular groups such as the acetyl, methyl, phosphate, ubiquitin and several others to 
lysine or arginine residues (Grant, 2001; Bannister and Kouzarides, 2011; New et al, 
2012). Such modifications regulate the chromatin either through direct modulation of 
chromatin conformation or indirectly by serving as signals to recruit additional regulators 
for chromatin re-structuring (Grant, 2001; Bannister and Kouzarides, 2011). One of the 
earliest identified and perhaps the most extensively studied modifications is histone 
acetylation (Bannister and Kouzarides, 2011). Two opposing families of enzymes 
namely the histone acetyltransferases (HATs) and histone deacetylase (HDACs) 
regulate the acetylation level of histone (Ropero and Esteller; 2007). HATs catalyze the 
addition of an acetyl group to lysine resides of histone 3 and 4. This neutralizes positive 
charge of histone that in turn weaken the interaction between DNA and histones (Iizuka 
and Smith, 2003). Consequently, acetylated lysine relaxes the chromatin structure, 
allowing access to genes and thus their expression (Iizuka and Smith, 2003).  
Opposing histone acetylation is the histone deacetylases (HDACs) family of 
enzymes (Bannister and Kouzarides, 2011). HDACs catalyze the removal of acetyl 
group from histone lysine residues (Bannister and Kouzarides, 2011; Johnstone; 2002). 
Removal of acetyl group increases ionic interaction between histones and DNA giving a 
condense chromatin structure and thus functions predominantly to repress transcription 
(Bannister and Kouzarides, 2011; Johnstone; 2002). In addition, HDACs can also 
regulate gene expression through interacting with nuclear receptors like estrogen 
receptor (ER) in the absence of ligand or with transcription factors or other chromatin 
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regulators (Ropero and Esteller, 2007). All HDACs across different species, including 
mammalian and Drosophila are classified into 4 classes, class I through VI, based on 
their homology to yeast orthologs, Rpd3, HdaI and Sir2 (Gregoretti et al, 2004; Ropero 
and Esteller, 2007). The sub-cellular localization and functions vary among these 
different HDAC classes (Ropero and Esteller, 2007). Class I HDACs, which are 
ubiquitously expressed, are nuclear localized while class II HDACs are expressed in 
tissue specific fashion and can shuttle between nucleus and cytoplasm (Ropero and 
Esteller, 2007). Class III and IV HDACs are comparatively less well understood. 
Numerous HDACs often function as components of large multimeric repressor 
complexes including NcoR and SMRT to regulate processes like cell proliferation, cell 
cycling and apoptosis (Wen et al, 2000; New et al, 2012; Glass and Rosenfeld, 2000; 
Guenther et al, 2000; Li et al, 2000). Importantly, ectopic HDACs expression is often 
implicated in various human cancers, making HDACs an important therapeutic target for 
cancer treatment (New et al, 2012; Hagelkruys et al, 2011).  
To date, Drosophila HDACs have been reported to regulate various 
developmental processes including imaginal disc and wing development and dendrite 
targeting (Zhu et al, 2008; Tea et al, 2010). However, while mammalian HDACs are 
frequently implicated with tumor formation in human, there are no known reports of 
HDACs’ involvement in regulating self-renewal of stem cells. 
 
1.9 Cancer stem cells hypothesis  
Cancer is a human disease that arises from aberrant proliferation of cells. It is 
one of the leading causes of death around the world. It is long established that mutation 
in tumor suppressor genes and/or aberrant expression of oncogenes are responsible for 
cancer formation in human. Nonetheless, the target cells of these transforming 
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mutations remain a mystery. Gaining recognition in cancer cell biology is the concept of 
tumor formation initiating from an abnormal group of stem cells called the cancer stem 
cells (Dalerba et al, 2007; Lobo et al, 2007; Nguyen et al, 2012). Like normal stem cell, 
cancer stem cell possesses the ability to self-renew and to generate an array of different 
cell types, contributing to the heterogeneous nature of cancer (Dalerba et al, 2007; Lobo 
et al, 2007; Nguyen et al, 2012). There are different ways in which cancer stem cells are 
formed. One way is subversion of normal adult stem cells residing in various organs 
(Passegue, E., 2006). Under normal circumstances, adult stem cells proliferate to 
generate progenitors for normal tissue function and maintenance or for wound healing 
and repair. Nonetheless, mutations in tumor suppressor genes like p53 or ectopic 
expression of oncogenes like Ras could subvert these normal stem cells, allowing them 
to bypass the restrictive measures imposed on cell proliferation (Passegue, E., 2006). 
Alternatively, cancer stem cells could also arise from differentiated progenitor cells that 
undergo reversion of the differentiation program in a process known as de-differentiation 
(Passegue, E., 2006). Differentiation is a unidirectional process that generates terminally 
differentiated cells that make up the functional units of any organs. Differentiated cells do 
not self-renew and are replaced over time by new differentiated cells generated by the 
adult stem cells in most organs. However, upon acquiring ectopic expression of 
oncogenes, these differentiated cells aberrantly express self-renewal genes (Friedmann-
Morvinski, 2014; Friedmann-Morvinski and Verma, 2014; Passegue, 2006; Krivtsov et al, 
2006). Consequently, the differentiated cells acquire stem cell signature and subvert to 







1.10 Type II neuroblasts as a model for studying cancer stem cells  
While the actual implication of cancer stem cells in human cancers remains to be 
further proven, studies using Drosophila type II neuroblasts could provide insights into 
the role of stem cells in tumorigenesis (Homem and Knoblich, 2012). Researches in the 
past two decades demonstrate that defects in asymmetric division of neuroblasts can 
lead to tumor formation (Chang et al, 2012). However, causes of such brain tumor 
phenotype in Drosophila are not restricted to defects in asymmetric division (Chang et al, 
2012). More recently, it was shown that genes involve in cell fate determination 
particularly those involve in type II lineages similarly cause brain tumor phenotype that is 
independent of asymmetric division defects (Weng et al, 2010; Xiao et al, 2012). 
Furthermore, these tumors initiated during larval development can bypass the 
programed proliferation exit at pupal stage allowing the subverted neuroblasts to 
continue proliferation even in the adult brain (Caussinus and Gonzalez, 2005). 
Importantly, these tumorigenic tissues are able to survive and proliferate even after 
cycles of serial transplantation into the abdomen of a healthy adult host fly (Caussinus 
and Gonzalez, 2005). In these several aspects, tumor formation resulting from 
subversion of type II neuroblasts resembles carcinogenesis in human. Thus, type II 
neuroblast lineages is a valuable model to understand the molecular mechanisms 
underlying the transformation of normal stem cells or differentiated cells into subverted 
stem cells that form tumor.  
 
1.11 Implications of Brm remodeling complex and HDAC3 in cancer formation 
One of the recent emerging concepts in cancer research is the involvement of 
epigenetic changes during cancer formation (Sharma et al, 2010). Unlike genetic 
alterations, epigenetic modification involves mitotically heritable changes of the 
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chromatin structure to regulate genes expression without any alteration to the primary 
DNA sequence (Sharma et al, 2010). Such modifications result in a set of epigenetic 
marks, which are specific for different cell types, developmental stages and even 
disease states (Sharma et al, 2010). In cancer biology, the concept of genetic alteration 
leading to cancer formation has been well recognized (Nguyen et al, 2012). However, 
with the recent advancement in epigenetic studies, evidence suggests the involvement 
of dys-regulated epigenetic alterations and thus hinting on a model of epigenetic induced 
cancer formation (Sharma et al, 2010). Alterations to the epigenetic mechanism can lead 
to global dys-regulation of gene expression including suppression of tumor suppressors 
and activation of oncogenes (Sharma et al, 2010). While it is unclear how such global 
epigenetic abnormalities occur in tumor cell, it is certain that such abnormalities are 
unlikely to result from a series of stochastic events (Sharma et al, 2010). Rather, genetic 
alteration of epigenetic regulators during the early stage of cancer formation is the more 
plausible explanation (Sharma et al, 2010).  
Indeed, various epigenetic regulators complex are found associated with various 
human cancers (Sharma et al, 2010; New et al, 2012; Reismann, 2009; Halliday et al, 
2009). One of the chromatin remodeling complex that is frequently associated with 
human cancers is the SWI-SNF complex (mammalian Brahma complex), an ATP-
dependent chromatin remodeling (Halliday et al, 2009; Reismann, 2009). Loss-of-
function mutations of SWI/SNF components are reported in approximately 20% of 
human cancers (Hohmann and Vakoc, 2014). The SWI/SNF complex plays a pivotal role 
in regulating DNA methylation, repair and replication, and inhibiting cell proliferation. 
One of the strongest evidence is the implication of mammalian SNF5 with the 
development of aggressive paediatric rhabdoid tumors, rhabdomyosarcomas, 
medulloblastoma and choroid plexus carcinomas (Halliday et al, 2009). Furthermore, 
other components of mammalian SWI/SNF complex are also associated with various 
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cancers including prostate cancer, non-small cell lung cancer, gastric, breast and 
bladder cancer (Halliday et al, 2009). Mutations in the ATPase subunit BRG1 or loss of 
BRM expression are correlated with poor prognosis in lung or gastric carcinomas 
respectively (Yamamichi et al, 2007; Reisman et al, 2003). Collectively, this body of 
evidence suggests that loss of SWI/SNF function reduces differentiation and enhances 
invasiveness and metastatic ability (Halliday et al, 2009). Further, recent works in the 
mammalian system had also demonstrated a context dependent oncogenic function of 
BRG1 in cancer development (Naidu et al, 2009). Such opposing functions of the 
mammalian Brahma remodeling complex in cancer development warrant a deeper 
understanding of this remodeling complex in various human cancers.  
In addition, BRG1 and BRM are known to promote deacetylation of chromatin to 
regulate expression of various genes that control cell growth and proliferation (Underhill 
et al, 2000). As mentioned in earlier chapter, HDACs catalyze the removal of acetyl 
group from the lysine amino acid on a histone, which allows histones to wrap DNA tightly 
to repress gene expression (Bannister and Kouzarides, 2011; Johnstone; 2002). 
Functioning as components of multimeric complexes such as NcoR, SMRT and Sin3A, 
HDACs regulate expression of regulators involved in cell proliferation, cell cycling and 
apoptosis (Wen et al, 2000; New et al, 2012; Glass and Rosenfeld, 2000). It was 
observed that up-regulated expression of HDACs is frequently implicated with various 
human cancers (New et al, 2012). Ectopic HDAC expression is proposed to repress 
tumor suppressor genes, which results in uncontrolled proliferation, leading to cancer 
formation (New et al, 2012). In particular, HDAC3 is frequently up-regulated in lung, 
prostate and colon cancer and that ectopic HDAC3 expression is associated with poor 
prognosis of the various cancers (Hagelkruys et al, 2011). Due to the frequent 
association of ectopic HDAC expression with human cancers, HDAC inhibitors (HDIs) 
are commonly used as anti-cancer agents in combinatorial cancer therapy (New et al, 
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2012). HDIs exert its anti-proliferative function through interfering cell cycling and 
mitosis, DNA damage response, inhibiting angiogenesis, inducing apoptosis or by 
regulating immune responses to tumorigenic cells (New et al, 2012). Nonetheless, 
somatic mutations of HDAC genes are also linked with human cancers though these are 
rare occurrences. For instances, HDAC4 mutations are associated with breast cancer 
(Sjoblom et al, 2006) while mutations resulting in truncation of HDAC2 protein are linked 
with human epithelial cancer cell lines (Ropero et al, 2006). Thus it is possible that 
implication of various HDACs in human cancer formation is tissue specific and that the 





















In stem cell biology, proliferation and differentiation are often maintained in an 
intricate balance. This balance is important during development for tissue homeostasis 
and tumor suppression. One important process that regulates this balance is the 
asymmetric division of stem cells. Asymmetric division allows stem cells to generate two 
daughter cells of distinct cell fates, a self-renewing daughter stem cell and a 
differentiating cell. Over the years, Drosophila neuroblast has gained popularity as an in 
vivo model for understanding the molecular and cellular mechanisms regulating stem 
cell biology, both during normal development as well as during the abnormal 
development of tumor formation. 
The objective of this thesis is to identify potential epigenetic regulators of 
neuroblast homeostasis and to delineate the underlying mechanism governing the 
balance between self-renewal and differentiation. We focus on understanding the 
potential role of the Drosophila SWI/SNF chromatin remodeling complex in neuroblast 
homeostasis. Given that Brm is the catalytic ATPase subunit of this chromatin 
remodeling complex we aim to: 1) determine the roles of Brm in the two different 
Drosophila neural stem cell lineages; 2) investigate the roles of the other components of 
Brm complex in the two neuroblast lineages; 3) identify, if any, histone modifier(s) that 
play(s) similar roles in regulating neuroblast homeostasis; 4) delineate the mechanism 
that underlies the regulatory function of Brm complex in neuroblast homeostasis and; 5) 







MATERIALS AND METHODS 
 
2.1 Fly Genetics 
2.1.1 Fly stocks and growth condition 
All fly stocks were raised at 25°C unless otherwise stated. Fly stocks were kept in 
vials or bottles containing standard fly food (0.8% Drosophila agar, 5.8% Cornmeal, 
5.1% Dextrose and 2.4% Brewer’s yeast). 
The following flies were used in this study: brmT362 (J. Treisman), erm1, erm2 and 
UAS-ErmCTHA (C.Y. Lee), UAS-BrmK804R (J.Skeath), UAS-Brm and snr1R3 (A.K. 
Dingwall), UAS-Snr1cdel (H. Richardson) 9D11-Gal4 (erm-Gal4; G.M. Rubin), bap601 (H. 
Jaeckle), brm2, bap55LL05905, mor1, hdac3N, snr16C hdac36C, snr101319, UAS-AOP, UAS-
HDAC3, pntp1Δ88, dMi-24, snr1 TRiP RNAi (BDSC #32372), hdac3 TRiP RNAi 
(BDSC#34778) and erm TRiP RNAi (BDSC# 26778) are from Bloomington Drosophila 
stock center. VDRC (Vienna Drosophila RNAi Center) RNAi lines used: Brm (GD37720 
and GD37721), Bap60 (KK103634), Snr1 (KK108599, GD12645, and BDRC#32372), 
Bap55 (GD24704), Dalao (KK194361, GD37682) Moira (GD6969), Bap180 (KK108618), 
Bap170 (GD34581), Osa (GD7810), Pnt (KK105390) dMi-2 (KK107204), nurf301 
(GD46645), Acf1 (GD33446) and ISWI (GD24505). Fly stocks generated in this study 
are listed in Table 1. Histone modifiers and their corresponding RNAi lines are listed in 
Table 2. The following tissue-specific drivers were used in this study: insc-Gal4; UAS-
Dcr2 (neuroblast driver), elav-Gal4; UAS-Dcr2 (pan-neural driver), ase-Gal4; UAS-Dcr2   
(type I neuroblats driver), the type II neuroblast driver: w; UAS-Dicer 2, wor-Gal4, ase-
Gal80/CyO; UAS-mCD8::GFP/TM3, Ser (Neumuller et al., 2011) and INP driver: erm-
Gal4 (II); erm-Gal4 (III), UAS-CD8::GFP. 
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Table 1: List of fly stocks generated for this study 
S/No. Stock genotype 
1 UAS-Dcr2; brm RNAi 
2 UAS-CD8::GFP; brm RNAi 
3 erm RNAi, brm RNAi 
4 hdac3 RNAi; brm RNAi 
5 notch RNAi; brm RNAi 
6 hdac3 RNAi; erm RNAi 
7 erm RNAi; UAS-CD8::GFP 
8 hdac3 RNAi; UAS-CD8::GFP 
9 notch RNAi; brm RNAi 
10 snr1 RNAi; UAS-CD8::GFP 
11 bap60 RNAi; UAS-CD8::GFP 
12 snr1 RNAi; UAS-Dcr2 
13 hdac3 RNAi; UAS-Dc2 
14 hdac3 RNAi; snr1 RNAi 
15 brm RNAi, UAS-Erm 
16 snr1 RNAi; erm RNAi 
17 UAS-CD8::GFP; UAS-Erm 
18 UAS-BrmRR; brm RNAi 
19 insc-Gal4; brm RNAi 
20 insc-Gal4, pnt RNAi 
21 elav-Gal4;; erm RNAi 
22 elav-Gal4; hdac3 RNAi 
23 pnt∆88, FRT2A brm2 
24 pnt∆88, FRT2A brmT362 
25 erm2; FRT2A brm2 
26 UAS-Erm, FRT2A brm2 
27 UAS-Erm, FRT2A 
28 FRT2A brmT362, UAS-Brm 
29 FRT2A brm2, UAS-Brm 
30 UAS-Dcr2; FRT2A brmT362, erm RNAi 
31 bap170∆65; FRT82B bap180∆86 
32 FRT82B osa308, bap180∆86 
33 erm-Gal4 (II); erm-Gal4 (III) 
34 erm-Gal4 (II); erm-Gal4, UAS-CD8::GFP 
35 UAS-Dcr2; erm-Gal4, UAS-CD8::GFP 
36 erm-Gal4; erm-Gal4, FRT2A brm2 








Table 2: List of histone modifiers and their corresponding RNAi lines 
S/No. Gene 
name  




1 enok Enoki mushroom CG11290 HAT KK108400, 
GD37527 
2 nej Nejire/CBP CG15319 HAT KK105115 
3 CG1894  CG1894 HAT GD41575, 
GD41574 
4 CG2051  CG2051 HAT GD33458 
5 Mof  Males absent on the 
first 
CG3025 HAT KK105370 
6 Rpb4 Rpb4 CG33520 HAT GD21985, 
GD23308 
7 Pcaf Gcn CG4107 HAT KK108943, 
GD21786 
8 YL-1 YL-1 CG4621 HAT GD21903 
9 Chm Chameau CG5229 HAT KK105542 
10 Dik Diskette CG7098 HAT GD46320 
11 lid Little imaginal discs CG9088 HAT GD42203, 
KK103830 
12 Ada2b  CG9638 HAT GD24076 
13 Sirt7  CG11305 HDAC GD18043, 
GD18045 
14 HDAC4  CG1770 HDAC GD20522 
15 HDAC3  CG2128 HDAC KK107073 
16 HDACX  CG31119 HDAC KK108098 
17 Sirt4  CG3187 HDAC GD40295, 
KK110639 
18 Sirt2  CG5085 HDAC KK103790 
19 Sir2  CG5216 HDAC GD23199, 
KK108241, 
KK105502 
20 Bin1 Bicoid interacting 
protein 
CG6046 HDAC KK105352, 
GD15710 
21 Sirt6  CG6284 HDAC GD22483 
22 Gug Grunge CG6964 HDAC GD13687 
23 Rpd3 HDAC1 CG7471 HDAC GD46929, 
GD30600, 
GD46929 
24 Sin3a  CG8815 HDAC KK105852 
25 Rtf1  CG10955 Methyl 
transferase 
KK110392 














29 set2  CG1716 Methyl 
transferase 
GD30707 
30 g9a  CG2995 Methyl 
transferase 
GD25474 
31 pr-set7  CG3307 Methyl 
transferase 
KK105422 









34 CG4565  CG4565 Methyl 
transferase 
GD5665 
35 mes-4  CG4976 Methyl 
transferase 
GD10836 
















39 ash2 absent, small or 






















Ash1 Absent, small or 





2.1.2 RNAi knock down in the larval brain 
UAS-RNAi stocks were crossed to various drivers to knock down gene-of-
interest.  Crosses were kept at 25°C for 24hrs for egg laying and were then transferred 
to 29°C and aged for 72hrs. Larval brains were dissected from wandering third instar 






2.1.3 Generation of neuroblast clones in larval brains 
Clonal analysis of mutants was performed using the Mosaic Analysis with a 
Repressible Cell Marker (MARCM) system as previously described (Lee and Luo, 1999). 
Mutants carrying the appropriate FRT (FLPase recombination target site) on the same 
chromosome arm were crossed to the corresponding MARCM driver in bottles and 
allowed to lay eggs for 24 hrs at 25°C.  Bottles containing laid eggs were aged further at 
25°C for 16hrs where the first instar larvae were then heat-shocked at 37°C for 2 hrs. A 
second heat-shock at 37°C for 2 hrs was performed at 10-16 hrs after the first heat 
shock. Larvae were further aged for 72 hrs at 25°C where wandering third instar larvae 
were dissected and the larval brains were processed for immunohistochemistry.  
 
The following MARCM drivers were used in this study: 
- FRT40A driver (Chromosome 2L): elav-Gal4c155, UAS-CD8::GFP, hsFLP122; 
FRT40A tub-Gal80/GlaBc  
- FRTG13 driver (Chromosome 2R): elav-Gal4, hsFLP; FRTG13 tub-Gal80; UAS-
nLacZ, UAS-CD8::GFP 
- FRT2A driver (Chromosome 3L): elav-Gal4, hsFLP; UAS-nLacZ, UAS-
CD8::GFP; FRT2A tub-Gal80/Tm6B, Tb, Hu 
- FRT82B driver (Chromosome 3R): elav-Gal4, hsFLP; UAS-nLacZ, UAS-
CD8::GFP; FRT82B tub-Gal80/Tm6B, Tb, Hu 
 
2.2 Molecular Biology 
2.2.1 PCR amplification of DNA fragments  
ESTs (Expressed sequence tag) used in this study are GH14092 (Erm), 
LD36356 (Brm), LD09078 (Bap60), GH08712 (Snr1), LD26355 (Bap180) (Drosophila 
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Genomics Resource Centre; DGRC). UAS-Osa (J. Tresiman) was used as template for 
PCR due to lack of Osa EST. Primers were designed according to the requirements from 
pENTRTM Directional TOPO® Cloning Kit (Invitrogen) or In-fusion® HD Cloning Kit 
(Clontech) using the gene sequence obtained from Flybase (www.flybase.org). Refer to 
Table 3 and 4 for primers used. Expand High Fidelity (Roche) PCR reaction kit was used 
according to manufacturer’s protocol, and PCR products were analyzed on DNA 
agarose gel. 
 
2.2.2 Agarose gel electrophoresis and gel extraction of DNA 
0.8% to 1.2% agarose gel was prepared for DNA separation and gel 
electrophoresis based on the size of the DNA products. DNA samples were mixed with 
6x loading dye (Promega) and loaded onto the agarose gel. DNA electrophoresis was 
performed at 100 Volts for 1 hr. SYBER® Safe (Invitrogen) was used for DNA 
visualization at 1:50,000.  
For PCR products purification, the specific PCR product band was excised and 
DNA was extracted using the QIAquick Gel Extraction Kit (Qigaen) according to the 
manufacturer’s protocol. Briefly, DNA fragment was excised from the agarose gel and 
was incubated with buffer QG at 50°C for 10 min to dissolve the gel. After the gel was 
completely dissolved, isopropanol was added to the sample, mixed and transferred to a 
QIAquick spin column. The column was centrifuged at 13,200 rpm for 1 min and was 
washed once with buffer QG and buffer PE respectively. DNA was then eluted with 30μl 






2.2.3 Molecular cloning strategies 
In this study, molecular cloning was performed either using the Gateway cloning 
(Invitrogen) or In-fusion® HD Cloning Kit (Clontech).  
 
2.2.3.1 Gateway cloning 
Gateway cloning is a recombination based cloning method that involves the 
generation of an ENTR construct, which is used for further cloning into various different 
destination vectors. ENTR construct was generated using pENTRTM Directional TOPO® 
Cloning Kit (Invitrogen). Briefly, purified PCR product was mixed with TOPO® vector at 
5:1 molar ratio in 1x salt solution and incubated for 2 hrs at room temperature (RT). 
Subsequently, 2μl of the reaction solution was used for bacterial transformation (refer to 
section 2.2.5) and clones containing ENTR vector with the correct insert were selected 
by Luria Bertani (LB) plates supplemented with 50μg/ml of Kanamycin. Positive ENTR 
clones were confirmed by sequencing. LR recombination (Invitrogen) was then 
performed between the destination vectors and the correct ENTR construct to obtain the 
various destination constructs. Clones were selected by 50μg/ml Carbencillin 
supplemented LB plates and confirmed by sequencing. The destination vectors used in 
this study are: pAHW (HA tagged), pAFW (Flag tagged), pAMW (Myc tagged) and 
pUASt (for transgenic fly generation).  
 
Table 3: List of primers used for pENTR cloning 
Primer Primer Sequence (5’ to 3’) 
Brm pENTR F CAC CAT GGC CTC GCC CTC T 
Brm pENTR R CTA GTC CAT GTC ATC GTC GTC A 
Snr1 pENTR F CAC CAT GGC ACT GCA GAC ATA C 
Snr1 pENTR R TCA CCA ACC AGT TGT GGT ATT GG 
Bap60 pENTR F CAC CAT GTC GCA ACG CTT TGC ACC T 
Bap60 pENTR R CTA GCC GTT GCG TAT GCC CAG CG 
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Erm pENTR F CAC CAT GGT TTA CTT TAG TCC GC 
Erm pENTR R CTA GAA GAG ACC GTT CAG TGC G 
ErmN pENTR R CTA CTGGTGGAAG GCCTTGT 
ErmC pENTR F CACC CTCACCCGCC ACATGCCC 
ErmC pENTR R CTA AAACACCTTG GCTATGA 
HDAC3 pENTR F CAC CAT GAC GGA CCG TAG GGT G 
HDAC3 pENTR R CTA ACT TTC TGC CGA ATC GGG C 
PntP1 pENTR F CAC CAT GCC GCC CTC TGC GTT TTT 
PntP1 pENTR R CTA ATC CAC ATC TTT TTT CTC AAT C 
Bap180 pENTR F CAC CAT GCT GAG CCG CAA GCG C 
Bap180 pENTR R CTA GTT GCA ACT GCG CCG TAT TTG 
 
2.2.3.2 In-fusion® cloning  
In-fusion® cloning was performed for direct cloning of large gene insert into 
destination vectors. The desired destination vector was first linearized by restriction 
enzyme (RE) digestion using the appropriate REs that flank the cloning insertion site and 
was gel purified. Primers were designed such that it contains 15 bp complementary to 
the ends of the linearized vector followed by 18-25 bps that are gene specific. PCR 
amplification was performed and the specific PCR product was gel purified and cloned 
into the linearized destination vector using the In-fusion® HD Cloning Kit (Clontech). 
Clones were selected on 50μg/ml Carbenicillin supplemented LB plates and confirmed 
by sequencing.  
 
Table 4: List of primers used for infusion cloning 
Primer  Sequence (5’ to 3’) 
Brm Inf F AGGAGGAGGACTCGAGATGGCCTCGCCCTCTCCGGCGAACA 
Brm Inf R AACGTCATCCCTCGAGCTAGTCCATGTCATCGTCGTCATCG 
ErmFL MBP F AGGATTTCAGAATTCATGGTTTACTTTAGTCCG 
ErmFL MBP R TTGCCTGCAGGTCGACTAGAAGAGACCGTTCAGTGCG 
ErmN MBP R TTGCCTGCAGGTCGACTACTGGTGGAAGGCCTTGT 
ErmC MBP F AGGATTTCAGAATTCCTCACCCGCCACATGCCC 
ErmC MBP R TTGCCTGCAGGTCGACTAAAACACCTTGGCTATGA 
PntP1 FL MBP F AGGATTTCAGAATTCATGCCGCCCTCTGCGTTTTTA 
PntP1 FL MBP R TGCCTGCAGGTCGACCTAATCCACATCTTTTTTCTCAATC 
Osa Inf F AGGAGGAGGACTCGAGATGAATGAGAAAATAAAGTCGCCG 
Osa Inf R AACGTCATCCCTCGAGCTACGCAACGGCTGTCGTT 
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2.2.4 Generation of RNAi resistant UAS-Brm construct  
RNAi targeted region of Brm was determined and its nucleotide sequence was 
altered without changing the protein sequence based on the theory of Degeneracy. The 
altered RNAi targeted length (red bar in Fig. 7) together with the 50 base-pairs (bps) 
fragments flanking upstream and downstream of the region (yellow bar in Fig. 7) was 
synthesize as a DNA fragment known as gBLock (IDT). The PCR insert containing the 
altered RNAi targeted sequence is generated using a series of PCR amplification. 
Firstly, Fragment 1 was PCR amplified using forward primer F1 that contains the EcoRI 
site at 3206bp position and reverse primer R2 (reverse complement of the first 20 
nucleotides of gBlock) with Brm EST as template (Fig. 7). Secondly, dual-templates PCR 
was performed using Fragment 1 and gBlock as templates and forward primer F1 and 
reverse primer R3 (reverse complement of the last 20 nucleotides of gBlock) to generate 
fragment 2. Thirdly, fragment 3 was PCR amplified using forward primer F2 (last 20 
nucleotides of gBlock) and reverse primer R1 that contains BglII site at 5196bp position. 
Lastly, fragment 4 was generated using dual-templates PCR with fragment 2 and 3 as 
templates and forward primer F1 and reverse primer R1. Concurrently, pUAST-Brm was 
restriction digested with EcoRI and BglII. Fragment 4 was then cloned into EcoRI and 
BglII digested pUAST-Brm vector using Infusion cloning. Clones were selected by LB + 
Carbenicillin plate and analyzed through PCR using primers (BrmRR VF and BrmRR 
VR) specific for the altered targeted length. Positive clones were confirmed by 
sequencing and amplified through maxi-prep before sending for pUAST-BrmRNAi resistant 







Fig. 7: Generation of RNAi resistant UAS-Brm construct. (A) Schematic to illustrate 
the primers designed to amplify fragment containing the altered RNAi targeted region 
with the upstream and downstream flanking gene regions that contain the EcoRI site and 
BglII site respectively. (B) Approach used to amplify fragment that contains the altered 
RNAi targeted region. Fragment 1 was first amplified using primer F1 (contains EcoRI 
site) and R2 using pUAS-Brm as template. Then dual-template PCR was performed 
using primer F1 and R3, and with fragment 1 and gBlock as templates to generate 
‘Fragment 2’. Concurrently, fragment 3 was amplified using primer F2 and R1 (contains 
BglII site). Lastly, dual-templates PCR was performed using fragment 2 and fragment 3 






Table 5: List of primers used to generate RNAi resistant UAS-Brm construct 
Primer Sequence (5’ to 3’) Comments 
BrmRR F1 AATTGGGTGCTGGAATTCGAGAAGTGGGCG Contains EcoRI site. 
BrmRR F2 CGCAGCGAGGAGGAGATTGAAATAT  
BrmRR R1  CTTCGTTGTAGATCTGTGCATTCTGGCATA Contains BglII site 
BrmRR R2 CCGAGCCTTTGGCGTTGAATTTTCG  
BrmRR R3 TTAAATATTTCAATCTCCTCCTCGCTGCG  
BrmRR VF GGCGGTCTGGGCCTGAATCTC To verify UAS-BrmRR 
construct BrmRR VR CTCGTCGTCCGGAACCTCATT 
 
2.2.5 E.coli bacterial culture and Heat-shock transformation  
E.coli strain XL-1 Blue was used in this study. E.coli was either cultured in LB 
broth (1% bacto-tryptone, 0.5% bacto-yeast extract and 1% NaCl pH 7.0) or plated on 
LB agar plates (1.5% bacto-agar in LB broth). LB broth or plates were supplemented 
with 50μg/ml Carbenicillin, 50μg/ml Kanamycin, 10μg/ml Gentamycin or 25μg/ml 
Chloramphenicol for different antibiotic selections.  
Competent XL-1 Blue cells were thawed on ice. 0.5-2μl of plasmid DNA was 
added to 100μl of competent cells depending on its concentration. Competent cells with 
plasmid DNA were incubated on ice for 30 min and heat-shocked at 42°C for 45 sec. 
Heat-shocked bacterial cells were immediately place on ice for 2 min before adding 
800μl of fresh LB broth and allowed to recover at 37°C with shaking at 220 rpm for 1 hr. 
Bacterial cells were briefly spin down at 2000rpm for 3 min, re-suspended in 100μl of LB 
broth and spread on LB plate supplemented with the appropriate antibiotic.   
 
2.2.6 Plasmid DNA extraction 
For small scale DNA amplification (up to 4-5μg DNA can be obtained), single 
colony was picked and inoculated into 3-5ml of LB broth supplemented with the 
appropriate antibiotic and was incubated overnight (at least 16 hrs) at 37°C with shaking 
at 220 rpm. Overnight culture was spun down at 13200rpm for 30 sec and the bacterial 
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pellet was processed for plasmid DNA extraction using the QIAprep Miniprep Kit 
(QIAGEN) according to the manufacturer’s protocol. Briefly, bacterial pellet was re-
suspended in buffer P1, and lysed under alkaline condition using Buffer P2. The lysate 
was subsequently neutralized and adjusted to high salt binding condition by addition of 
Buffer N3, followed by centrifugation at 13,200 rpm at 4°C for 15 min. Supernatant was 
transferred to a Qiaprep spin column for absorption to the silica membrane by 
centrifugation at 13,200 rpm for 1 min. Column was then washed with buffer PE and 
DNA was eluted with 30μl of autoclaved water. DNA samples were stored at -20°C or 
were analyzed by agarose gel electrophoresis. 
For large scale amplification of up to 100μg DNA, single colony was picked and 
inoculated into 5ml of antibiotic supplemented LB broth and incubated at 37°C for 8-10 
hrs. The starter culture was then diluted into 50ml of antibiotic supplemented LB broth 
and incubated overnight (at least 16 hrs) at 37°C with shaking at 220rpm. Bacterial 
culture was spin down at 6000g for 15 min at 4°C. Bacterial pellet was processed for 
DNA extraction using QIAGEN HiSpeed™ plasmid Midiprep Kit (QIAGEN) according to 
manufacturer’s protocol. Briefly, bacterial pellet was re-suspended in buffer P1, lysed 
using buffer P2 and neutralized with buffer P3. Neutralized lysate was passed through a 
QIAflter cartridge into an equilibrated HiSpeed Midi Tip and was allowed to enter the 
resin by gravity flow. The DNA bounded HiSpeed tip was then washed with Buffer QC 
and DNA was eluted with Buffer QF followed by precipitation with isopropanol. Solution 
was then centrifuged at 15,000g for 30 min at 4°C and DNA pellet was washed with 70% 
ethanol, air-dried and re-suspended in 300μl of autoclaved water. DNA samples were 






2.2.7 Reverse Transcription – First strand cDNA synthesis 
First strand complementary DNA (cDNA) was synthesized using ProtoScript® II 
First Strand cDNA Synthesis Kit (New England BioLabs; NEB) according to the 
manufacturer’s protocol. Briefly, 1μg of total RNA extract was used as template to 
synthesized cDNA using d(T)23 VN primer in 1X ProtoScript II Reaction Mix at 42°C for 
1 hour. Reaction was terminated by incubation at 80°C for 5 minutes. cDNA was then 
stored at -20°C or was used for quantitative PCR. 
 
2.2.8 Quantitative-PCR   
Approximately 20ng of cDNA template was added to 1X SsoFastTM EvaGreen® 
supermix (Bio-Rad; contains dNTPs, Sso7d-fusion polymerase, MgCl2, EvaGreen dye 
and stabilizers) and quantitative real time PCR was performed using Bio-Rad CFX96™ 
Real-Time PCR system. Program used is as follows:  
95°C for 3 minutes 
56°C for 30 second  
Plate read 
Melt curve; 65°C - 95°C with 0.5°C increment for 5 second + plate read 
Results were analyzed using REST excel file.  
 
Table 6: List of primers used for Q-PCR 
Primer  Sequence (5' to 3') 
Act5C RT F CAG ATC ATG TTC GAG ACC TTC A 
Act5C RT R TCA TGA TGG AGT TGT AGG TGG 
Adf1 RT F CCC ATC CGC ATG AAA TTA CT  
Adf1 RT R CTT GTT GTG CTG TGC CAG AA  
Ago RT F ACA TTC TTG TCT CGG GCA AC 
Ago RT R GCA CCC TCA ACA TCA AAG TCG  
Apt RT F CAC CAG CAG TGG TAG CAT GT 
Apt RT R GCA CCT CCA GGA TCT TCA T  
apt RT F2 CAG TCA GCA CCA ATG CCA A 




Arp5 RT F AGG AAG AGG ACG ATG GCT TT 
Arp5 RT R ATC ATG CTG GGC TGG AAT AG 
Ase RT F CAC CTA CCA ACT GCT GAC G 
Ase RT R GCT GCT GCT GCT AAT GTT G 
Bab1 RT F CAG CAA CAG CAA CAG CAG CA 
Bab1 RT R TGA GGA AGA TGA GAC ACT GGC 
BEAF32 RT F CCT GGA TCA GCC TGA GAA GC 
BEAF32 RT R AGT AGT CGT CGT CCT TGG TGA 
Brat RT F4 AGA CTG CGT AGC AAG CAA GAG 
Brat RT R4 CAG AGA TGG TGT CGG TGA GG  
Brm RT F TTG ACT GAA AAG GAG TGG CTG 
Brm RT R CAT CTG CTT CTT GGA CCG C 
CG10137 RT F1 ATG CGT CTG CGT AAC TTC CT 
CG10137 RT R1  AAC ACG GAG TAA ACG GCA TC 
CG12268 RT F1 GGT AAC AAG CAG ACG GGT GT 
CG12268 RT R1 TGA CGC AGA AAA GGT GGT GG  
CG12333 RT  R GTC CAG CAG CGG CTC CTC 
CG12333 RT F CAG ATG ATC GTA CAA TCA AGG TC 
CG14813 RT F1 AAG CTG TCT CCC AAC CAC AC 
CG14813 RT R1 CAC TTG AGC ACA CCC ACA TC 
CG15072 RT F1 GGA GGT GTC AAT GGT GCG AA 
CG15072 RT R1 TGA TGG TGA GGT TGT GCA GG 
CG17803 RT F A CTT GCT CCG TCA CAA TAGG 
CG17803 RT R TCTTCCTTTGATTTCACCCG 
CG17803 RT F2 CGG GTG AAA TCA AAG GAA GA 
CG17803 RT R2 GTC ACA GCG AAT GGG AAA CT 
CG1785 qPCR F2 CGT AAA TCT GCC CGA GGA TA 
CG1785 qPCR R2 GCC GTT CCT TGA GGT CAT TA 
CG18292 RT F GACCACCCAAACTTCGGC 
CG18292 RT R CAGCGACTCCTCCTCTCATT 
CG1845 RT F CGC AGC AAG CAC AGT GAG GA 
CG1845 RT R CAC CAG GAA CAC AAT CTC GT 
CG2051 RT F TGAAACTCAATCCCCTCCAG 
CG2051 RT R CATTCGTTGTTGAACCGTTG 
CG2051 RT F2  CGGCTTAACGCGGTCTATTA 
CG2051 RT R2 GGCAATGGTGCTCTGGTACT 
CG2991 RT F GGACAAGGGCTTCACCATTCA 
CG2991 RT R CGC TGA CCT CCT CGC AAA 
CG32767 qPCR F2 TCCACCAACAACAACAGCAC 
CG32767 qPCR R2 CTTCAGCGACTTCAACACCA 
CG32767 RT F GCAACAGCATCACCATCATC 
CG32767 RT R AGCCGAAAGTCATCGTCATC 
CG33116 RT F1 GTACAACACGGGCATCCTCT 
CG33116 RT R1 GATTCGCCATAGCACTGACA 
CG3842 RT F1 AATCTGCTGCTGGATCGACT 
CG3842 RT R1 GCCCCAAAGAACTTGCTGTA 
CG42666 RT F CACAACACCCTGATCGACAC 
CG42666 RT R CTAATCGTCCCAGCTCCAAG 
CG42666 RT F2 GACACCATCCTTATCGGACAT 
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CG42666 RT R2 CCACAGCATCAGTTCCATA 
CG43867 RT F1 TCAGGAACTGGAATCGGAAC 
CG43867 RT R1 TTTGCGAGGCTCTACCCTTA 
CG6022 RT F1 CCCAAAGTCACCGAGGATGG 
CG6022 RT R1 CCTGCTCGTTGTTGGCATTG 
CG6343 RT F1 GCTCCGACAGAACACCATCG 
CG6343 RT R1 CGCTGAACACCTTTGACTGC 
CG6783 RT F1  CACCCTGACTACCACCTCCA 
CG6783 RT R1 CTTGTCGCCCTTCTGCTCC 
CG7379 RT F AAC AAC GGA AGC TCT CTG GA 
CG7379 RT R TAC TGG CAT TGG CAT TTG AA 
CG8481 qPCR F2 CTGACCACCGAGGGAATG 
CG8481 qPCR R2 CCA ATG CGT TCG TAG AAT CC 
CG8790 RT F1 CGT CGG AGG AAT CGT TGG AA 
CG8790 RT R1 CTCCTGGCGGTAGACCCTAA 
CG9009 RT F1 CAGAATGTGCGTTACGAGGA 
CG9009 RT R1 GATGTGAAAGAAGGGCAGGA 
CG9057 RT F1 AGTCTGGCTGTCAACGGAGT 
CG9057 RT R1 CTGTCGGGAGACATTTCGAT 
Chm RT F TATCAGCGAAAGGGTTACGG 
Chm RT R GAAGGGTGCTCACAATGTCG 
Cic RT F  ACCGCAAGGTCCTGGAGACG  
Cic RT R ACT GGC ACT CAA TGT GGT CG 
Cic RT F2 AATCCTCATCGCCCATCATA 
Cic RT R2 GCA CCT TTC ATC GGT GAC TT 
Crol RT F GTCGCAGAAGCAGCAAGCA  
Crol RT R TGGATGGACAACTGAAGCAG 
Dbo RT F TGCTTGGAGGATTTCTCTAC 
Dbo RT R TAG GCG GAA CCA TCA AAG C 
Dfd RT F GTAGCGAAGAAACCCACCAA 
Dfd RT R TCG GAT TGT TGC TGT TGA AG 
Dpa RT F AGGCTCTCAAGCAGTCGG  
Dpa RT R GCA CCT CCT TCA GGG CAT 
Dpa RT F2 CTT ATC AAC AGC CGC TCG C 
Dpa RT R2 CCC TCA TCT TGC ACC TCC TTC A  
Dpn RT F ACA GGT TCC GCT GCT CCG 
Dpn RT R GGC AGT GTG TGG ATG AGG TT 
Drat qPCR F2 TCCCGATCACCATAATCCAC 
Drat qPCR R2 TCC GAG GAC ACT GAG GAC A 
E2F RT F GGAGAGCAACAACGGCAGTA  
E2F RT R TGATGGACACAAAGGCGATA 
E2F RT F2 ACAGCAACAGCAGCAGTGTC  
E2F RT R2 ATCCGAACCGAAGTCAAACA 
Ear RT F CAAGTCCAAGCAGAACGACA 
Ear RT R CAG GGG GTT CTA TAA AAG CAC C 
Erm RT F1 CAG CGT CTA CTG CCA CTT CC 
Erm RT R1 TGT GGG TCA GCT TGT GGT TCT T 
Erm RT F2 ATG CCA CCC ACC TAC GAC AG 
Erm RT R2 GGA TTA CTC GTC TCG CCG CT  
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Erm RT F3 TGT CTA CAC GGA ACT CAG GGC 
Erm RT R3 GCA GAA CCT CAG CAG CCA C  
Erm RT F4 TGGCTCCACCTCACGATTAT 
Erm RT R4 TCCGCATAGTATCGCTGTCA 
Ftz RT F GACGAGACGCAACTGAACAA 
Ftz RT R CACTGACGGATAGCAGGTGA 
ftz-f1 RT F2 GCA AAG TGC TCG ACC AGA AT 
ftz-f1 RT R2 CAC TCC CAA CAA ACC CAG AC  
Fz RT F CAT CCT TTC TGG CGT TTG TT 
Fz RT R GGG CGG GCT TCT GGA GAT  
Fz RT F2 ACTGGGCTGCTTGTTCTACG 
Fz RT R2 GACCATCGTCTTGCTGGAAT 
Grunge RT F AAC AGG CGG CAC AGC AAG  
Grunge RT R AGA CGC TCC CTC TCC ATC TGC  
HDAC3 qPCR F1 GACATCGTCATCGGCATTC 
HDAC3 qPCR R1 CCTCCTTTAGCGGCACATTA 
HDAC4 RT F GGCACACAGCAAGCATTCTA 
HDAC4 RT R TGG GCA TCA CAA CGG TAC GG 
HDAC4 RT F2 GCCATCAATACGCTCCAGAA 
HDAC4 RT R2 GGTTTCATCCTGATCCATCG 
Klu RT F GCA GCA CAC TCC ATC TTC CA 
Klu RT R GCC ACA TTC TTC GTC ACC GA 
Kuz RT F GAGAAGAAGCGATGGACGAG 
Kuz RT R CTGTGGATGAGTTGGTGGTG 
Kuz RT F2 GCGAATCAAGCGAGAAGAAG 
Kuz RT R2 CATTTGCTGCTGTCCATTTG 
lilli RT F GCCGTCCTCCATATCACCAT 
lilli RT R GCATCCCTGAGCGTCTTGAGA 
LqfR RT F TCA ACA GGA GGA GGA GAG TC 
LqfR RT R GGT CAT CGC TGG CAA CAG T 
Mad RT F CTACCACCACGGATTCCATC  
Mad RT R TGA GCA CCT TGT CCA GCC ACT 
Mam RT F2 CCAGTGCCAGTTCCATTAGC  
Mam RT R2 CCTGCAGATTGAAGTTGTCGT 
Med17 RT F ATG TCC TGG ACC GTG CTG TC 
Med17 RT R CCT CAC CTC CTT GAA TGT GC 
mid RT F CAACTCCCCCTATGCCCA 
mid RT R GGA CTG AAC CGC TGA TAC TGG 
NFAT RT F ACACCACTACCATCACCACG 
NFAT RT R TACCGCTCCAACCGCTGC 
Oc RT F GGCACAATCAGTACCAGCAA 
Oc RT R TACTTATCCTGCGGCGACAT 
Oc RT F2  GGCACAATCAGTACCAGCAAT 
Oc RT R2 TACTTATCCTGCGGCGACAT 
Opa RT F2 TTCTGCCTCCGCCTACCT 
Opa RT R2 GATGGTGTCCGAAATGGTTC 
Pax RT F CGGACTACCACAATCTGTTCA 
Pax RT R GATGCCACTGCGAGTTCAG 
Pb RT F GTTTTCAACAACAGGCTCAAG 
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Pb RT R ATT GTG GTG GGC GTG GAT GG 
Pb qPCR F2 AGC AGC AGA ACG ACC ACT TC 
Pb qPCR R2 CTCCACTCCCGTTTCCACTA 
Pgk qPCR F2 GCATCGAAAACCTGGACTTG 
Pgk qPCR R2 GACATCAGCACCACCGACTT 
PntP1 RT F1 TGG ACA GCG ATA AGG AGC AG 
PntP1 RT R1 GAT GAG GCA CTC GAC GAG GA 
PntP1 RT F2 GCG ATG CGA ATG CCT ACT ACA 
PntP1 RT R2 CAC AGA CAA AGC GCT AGA CAT A 
Rab8 RT F GCCGATGTCGAGAAAATGC 
Rab8 RTR CTT GGG TGG GTT GTT CGC  
Rabphilin RT F GATGCTTCTCTCGCTCTGCT 
Rabphilin RT R ATCCTTGTCCCACACGGTCA 
Rabphilin RT F2  GCACGCTCAATCCCATCTAC 
Rabphilin RT R2 CCG ATC ACT TCC ACG AGA AAT G 
Rept RT F TGCTGGACATTGAGTGCTTC 
Rept RT R AATCAGTTGGATGGCGTAGC 
Rich qPCR F2 GGT GAC GAC TGC CTG TAC CT 
Rich qPCR R2 TAA GAA TGC TGC CTG TGT GC 
RNA Pol II RT F CCT TCA GGA GTA CGG CTA TCA TC 
RNA Pol II RT R CCA GGA AGA CCT GAG CAT TAA TC 
Rpn5 RT F GGTTTGTGCCGTGCTTTATT 
Rpn5 RT R CCATGCTTGGTGCTATCCTT 
Rp49 RT F TGT CCT TCC AGC TTC AAG ATG ACC 
Rp49 RT R CTT GGG CTT GCG CCA TTT GTG 
salm RT F CGC TCT GGT GAT GAC TTC AA 
salm RT R CTGACTGGCTTCTCCTTTGG 
Salm RT F2 AGACATTCCCCTGCCACTC 
Salm RT R2 GCG ATC TTC GTT CCA CTC AC 
Sea RT F  CAC CAT TCT GAA ACA GGG C 
Sea RT R CAC ACA CGA CCT AAT CTT GGC 
Sea RT F2 ATCCCAAGTTCAGGGGATTC 
Sea RT R2 GCTCCAAACACTCCAACCAC 
SF1 RT F GGATCACAAGTCCTGGCAAT 
SF1 RT R GTCTTAGCAGAAGCGGATGG 
shn RT F CGG AAT TAG TCT CAC TGA A 
shn RT R CTT CTC GCC ACT GCT TTC C 
Shn RT F2 GCAACACACCCAAGCGAGCCA 
Shn RT R2 TGAAGCAGCCACGGGAACG 
Sim RT F TACGATGCGACGGTGGATGT 
Sim RT R AGG TGG CGT ATT GGT ATT GC 
Sim RT F2 TTTATCCGCCCTTGAACGAC 
Sim RT R2 GCATCTCCGTGGAGTAAACG 
Slit RT F CTT TGA CTT CAG CCG TGA CA 
Slit RT R TAG ACG CTC CAA GTC CTC GT 
SoxN RT F2 CGA GGA GCA GCA GCA GCA  
SoxN RT R2 CTCGTGGCCAGGATGATAGT 
SrpRbeta RT F GTCTTTGTGGTGGACTCGGT 





2.3 S2 cell culture and plasmid transfection   
Drosophila S2 (Schneider 2) cells were grown in 15ml of Shield and Sang M3 
Insect medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS) in 
250ml flask (BD) at 25°C without CO2.  
1.5 x106 S2 cells were seeded per well of 6-wells plate (BD) and incubated 
overnight at 25°C. Transfection was performed using Effectene transfection kit (Qiagen) 
according to the manufacturer protocol. Briefly, a total of 0.4μg plasmid DNA was 
condensed by adding into 100μl of DNA condensation buffer (Buffer EC) followed by 
3.2μl of enhancer and incubated at room temperature for 5 minutes. 10μl of Effectene 
was then added and incubated at room temperature for 10 minutes. 600μl of growth 
medium was added to the DNA-Effectene complex mix and added to the cells in a single 
well. Transfected S2 cells were incubated at 25°C for 48 hours before harvesting. 
 
 
SrpRBeta RT F2 CGT CTG CCA GGT TAG TGG AT 
SrpRBeta RT R2  CTT GTG GGC AGT AAC CGA GT 
Ssb-c31a RT F GAT AGC GAT AGC GGT CCA GA 
Ssb-c31aRT R GAC TTC TTC GGC CAC TTC AA 
Su(var)205 RT F ATC CCG AAA CTG AGA ACA CG 
Su(var)205 RT R CAC GCC TTT GAA CTG AAT GA 
Tap42 RT F GGA CAC CAC CAC CAT CAT CA 
Tap42 RT R GCA CCA CAT CCT TGT ATT CAT CCA 
Tbp1 RT F AAG CCC GTG CCC GTA TTA TG 
Tbp1 RT R AAG TCA TCC GTG GAT CGG GAC 
Tna RT F GGA GAA GTC ACT CAG CGA T 
Tna RT R TGG GCT GTA TCG TTT ATG GC 
Tup RT F ACC TAC CTG GAG AGC GAT GA 
Tup RT R CCG TTA CCT TCT GGA GCA TTT 
Uba2 RT F TGG TGT GAT CCT CAA GTG CG 
Uba2 RT R TGC TTG GTC TTC GTC TTC CT 
Xrp1 RT F  TTC AGC CCT TCG CCA GCC A  
Xrp1 RT R  ACG CAG TCG CAG ATT CTC G  
Zfh1 RT F GGA ATG GAG GTG GAG TGA TG 
Zfh1 RT R CGC ATG GTG GTG AAA GAA C  
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2.4 Total RNA extraction from larval brains 
50-60 wandering third instar larvae were dissected in cold PBS and larval brains 
were collected in 500μl of TRI reagent (Sigma-Aldrich). Larval brains were homogenized 
using pestle and 100μl of bromochloropropane was added to reduce genomic DNA 
contamination. Mixture was centrifuged at maximum speed at 4°C for 15 minutes and 
the aqueous phase of the solution was transferred to a fresh tube. RNA was then 
precipitated by addition of 400μl of isopropanol, mixed and centrifuged at maximum 
speed for 5 minutes at 4°C. RNA pellet was washed with 75% ethanol, air-dried and re-
suspended in 20μl of Diethylpyrocarbonate (DEPC)-treated water and stored at -80°C or 
was used for quantitative –PCR (Q-PCR). 
 
2.5 Biochemistry       
2.5.1 Western blot          
2.5.1.1 Preparation of larval brain protein samples    
50 wandering third instar larvae were dissected in cold PBS and larval brains 
were collected in 150μl of RIPA buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with 
complete protease inhibitors (Roche). Larval brains were then homogenized using a 
pestle and 50μl of 4x SDS gel-loading buffer (200 mM Tris-HCl (pH 6.8), 400mM 
Dithiothreitol (DTT), 8% SDS, 0.4% bromophenol blue, 40% glycerol) was added and 
mixed. The protein lysate was boiled at 95°C for 10 min and was either stored at -20°C 






2.5.1.2 SDS-PAGE electrophoresis 
Protein samples were loaded onto a SDS-PAGE gel in a minigel apparatus (Bio-
Rad). The gel was electrophoresed at 80 Volts (V) until the dye front ran past the 
stacking gel before switching to 100V for approximately 2 hrs. Proteins were transferred 
onto a Hybond C-extra nitrocellulose membrane (Amersham) using a Trans-Blot 
Electrophoretic transfer cell (Biorad) either at 100V for 2 hrs at room temperature or at 
30V for 12-16 hrs at 4°C.  
 
2.5.1.3 Immuno-blotting  
Transferred membranes were blocked in 10% milk in TBST (1×TBS, 0.1% Triton 
X-100) for 1 hr at room temperature. Membranes were then incubated with primary 
antibodies at room temperature for 2 hrs or overnight at 4°C. Following primary antibody 
incubation, membranes were washed 3 times with TBST, each for 10 min. Membranes 
were then incubated with the appropriate HRP conjugated secondary antibodies for 1 hr 
at room temperature. The membranes were then washed 6 times with TBST, each for 10 
min before detecting the proteins through chemiluminescence using the ECL western 
blotting substrate (Pierce; Thermo Scientific). Primary antibodies used for western 
blotting were: mouse anti-Myc (1:2000, Abcam) and mouse anti-Flag (1:1000, Sigma). 
Secondary antibodies used were: HRP conjugated anti-mouse IgG antibody, anti-guinea 
pig IgG antibody and anti-rabbit IgG antibody (immuno Jackson; 1:5000).          
 
2.5.2 Expression of MBP fusion protein  
MBP or MBP fusion proteins were expressed in BL21 cells as induced by 0.5mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 18°C overnight. Bacterial cells were 
spun down at 6000g for 15 minutes. Bacterial pellet was re-suspended in 40ml of 
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column buffer (20mM Tris HCL pH7.4, 0.2M NaCl and 1mM EDTA) per litre of bacterial 
culture and sonicated at 30% amplitude microns power with 16 cycles of 30 seconds 
pulsing with 30 seconds resting intervals. Bacterial solution was centrifuged at 10,000 
rpm at 4°C for 30 minutes and bacterial lysate was transferred to a fresh tube. Bacterial 
lysate was incubated with amylose resin (New England BioLabs) at 4°C for 3 hours and 
centrifuged at 3000 rpm for 3 minutes. MBP or MBP fusion protein bound resins were 
washed with cold column buffer thrice and stored at 4 °C in column buffer. 
 
2.5.3 Co-immunoprecipitation  
Transfected S2 cells were harvested and washed once with cold PBS. S2 cells 
were then lysed in 500μl of lysis buffer (25 mM Tris pH8/ 27.5 mM NaCl/ 20 mM KCl/ 25 
mM sucrose/ 10 mM EDTA/ 10 mM EGTA/ 1 mM DTT/ 10% (v/v) glycerol/ 0.5% Nonidet 
P40) supplemented with complete protease inhibitors (Roche) at 4°C for 30 minutes. 
Cell suspensions were centrifuged at maximum speed for 15 minutes at 4°C and cell 
lysates were collected in fresh tubes. Cell lysates were then pre-cleared by incubating 
with 20μl of protein A/G beads (Pierce) at 4°C for 30 minutes, followed by overnight 
antibody incubation at 4°C. 35μl of protein A/G beads were added to cell lysates and 
incubated at 4°C for 2 hours. Beads were then washed thrice with cold PBS. 30μl of 2x 
SDS gel-loading buffer was added to the beads and boiled at 95°C for 10 minutes before 
storing the samples at -20°C. Bound proteins were detected by western blotting.   
 
2.5.4 MBP pull-down assay 
Transfected S2 cells were harvested and washed once with cold PBS. S2 cell 
pellet was then re-suspended in 1ml lysis buffer and incubated at 4°C on an orbital 
rotator for 30 minutes. Cell lysate was then centrifuged at 13,200 rpm, collected and 
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further diluted with lysis buffer to a final volume of 4ml. MBP fusion protein bound beads 
were washed 3 times with lysis buffer and spun down at 3000 rpm for 3 minutes. MBP 
fusion protein beads were then added into diluted cell lysate and incubated at 4°C on a 
nutator for 3 hours. Solution was centrifuged at 3000 rpm for 3 minutes and supernatant 
was discarded. Beads were washed thrice with lysis buffer, each for 7 minutes on a 
nutator in 4°C followed by centrifugation at 3000 rpm for 3 minutes. SDS gel-loading 
buffer was added to beads and boiled at 95°C for 10 minutes. Samples were separated 
by SDS-PAGE and analyzed through western blotting. Lysis buffer was supplemented 
with complete protease inhibitors in this assay. 
 
2.6 Immunohistochemistry     
2.6.1 Antibodies  
Primary antibodies used were: guinea pig anti-Dpn (1:1000, J. Skeath), anti-Insc 
(1:1000); rabbit anti-aPKCζ C20 (1:100, Santa Cruz Biotechnologies); guinea-pig anti-
Numb (1:1000, J. Skeath); mouse anti-Mira (1:50, F. Matsuzaki); rat anti-CD8 (1:250, 
Caltag laboratories); rabbit anti-GFP (1:500, Molecular Probes); rabbit anti-Asense 
(1:1000, Y.N. Jan); rabbit anti-PntP1 (1:100, J. Skeath); rabbit anti-Brm (1:100, L. 
Zhang); rat anti-phospho-Histone H3 (1:1000, Cell Signaling); rabbit anti-phospho-
Histone H3 (1:200, Sigma); mouse anti-dMyc (1:5, B. Edgar).  
Secondary antibodies used were: Alexa-Fluor-488 (Green color), Alex-Fluor-555  
(Red color), Alex-Fluor-405 (Grey color) and Alex-Fluor-633 (Blue color) (Molecular 
Probes) at 1:500 dilution.  DNA was stained using TO-PRO3 (Molecular Probes) at 





2.6.2 Larval brains fixation and staining   
Third instar larval brains were dissected and fixed with freshly prepared 3.7% 
formaldehyde in PBS for 15 min at RT. Brain samples were then washed thrice with 
0.3% PBS-T (1x PBS, 0.3% Triton X-100), each for 10 min. Fixed brains were blocked 
with 3% bovine serum albumin (BSA; Sigma -Aldrich) in 0.3% PBS-T for one hour and 
then incubated with primary antibody in 3% BSA overnight at 4°C. Brain samples were 
washed thrice with 0.3% PBS-T each for 10 min before incubating with secondary 
antibody diluted in 0.3% PBS-T for 1.5 hours. Brain samples were washed twice with 
0.3% PBS-T each for 10 min, followed by incubation in 0.3% PBS-T with a DNA dye 
ToPro-3 (1:10,000, Invitrogen) for 20 min. Larval brains were mounted in vector shield 
(Vector Laboratory) for confocal microscopy. Images were obtained using a Zeiss LSM 














CHAPTER 3  
THE DROSOPHILA SWI/SNF CHROMATIN REMODELING 
COMPLEX REGULATES NEURAL STEM CELL HOMEOSTASIS 
 
3.1: Overview 
 In a genome-wide transgenic RNA interference (RNAi) analysis in Drosophila 
larval brain neuroblasts that we performed, knock down of osa, a component of the 
Drosophila SWI/SNF complex, resulted in neuroblasts over-growth phenotype (Sherry 
Aw and Hongyan Wang). SWI/SNF complex/Brm chromatin remodeling complex is a 
multimeric complex involved in the epigenetic regulation of almost the entire Drosophila 
genome. Brm is the ATPase subunit of the Drosophila SWI/SNF chromatin remodeling 
complex (Reisman et al, 2009). In humans, various components of SWI/SNF complex 
are implicated in various human cancers (Reisman et al, 2009). These observations 
suggest that Brm complex functions as a tumor suppressor, however, its underlying 
mechanism remains largely uncertain. Thus, the neuroblast over-growth phenotype of 
Drosophila brm loss-of-function could serve as a model to delineate the tumor 
suppressor function of this epigenetic regulator.  
To understand the roles of Brm complex in neuroblast homeostasis, I examined 
the loss-of-function of various components of Brm complex for neuroblast over-growth 
phenotype. I demonstrated that knock down of brm resulted in ectopic neuroblasts within 
type II lineages. Consistent with the knock down phenotype, clonal analysis of two brm 
mutant alleles showed neuroblast overgrowth phenotype in type II lineages while type I 
lineages were normal. Further, loss-of-function of other brm complex components 
resulted in similar ectopic neuroblasts formation in type II lineages while type I 
neuroblast lineages were unaffected. Upon further characterization, I observed that type 
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II neuroblast over-growth is independent of defects in asymmetric cell division. Rather, 
loss-of-function of brm resulted in de-differentiation of the INPs back into neuroblasts. 
Moreover, using a genetic enhancer screen, hdac3 was identified as an enhancer of 
brm, suggesting that HDAC3 functions synergistically with Brm complex to regulate 
neuroblast self-renewal. Severe neuroblast over-growth was also observed in snr16C 
hdac36C double mutant. In a series of co-immunoprecipitation and MBP pull down 
assays, I demonstrated that Brm and HDAC3 associate as a protein complex in vitro and 
that Brm, Bap60, Snr1 and HDAC3 interact physically with the type II specific 
transcription factor, Earmuff (Erm). Furthermore, erm genetically enhanced neuroblast 
over-growth phenotype of brm and snr1, while brm suppressed premature differentiation 
induced by ectopic expression of Erm. In addition, hdac3 genetically enhanced type II 
neuroblast over-growth of erm. Taken together, this body of evidence suggests that Brm 
complex, HDAC3 and Erm function as a novel protein complex to regulate type II 
neuroblast self-renewal by inhibiting de-differentiation of INPs.  
 
3.2: Results 
3.2.1: Brahma suppresses the formation of ectopic neuroblasts in type II lineages 
Knock down of brm in larval brain neuroblasts caused formation of ectopic 
neuroblast as revealed by neuroblast marker, Miranda (Mira) (Fig 8A,B). Furthermore, 
the number of cells expressing proto-oncogene, dMyc, was significantly increased upon 
knock down of brm (Fig. 8C,D), suggesting an increase in the number of cells 
undergoing cell cycling. To determine the function of Brm in different neuroblast 
lineages, brm RNAi knock down was driven using type I specific asense (ase)-Gal4 
(henceforth referred to as type I driver) and type II specific worniu (wor)-Gal4, ase-Gal80 
(henceforth referred to as type II driver) driver respectively. While knock down of brm by 
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RNAi using type I driver did not cause neuroblast over-growth phenotype (Fig. 8E,F), 
knock down of brm in type II lineages resulted in formation of ectopic neuroblasts. Each 
control type II lineage always contained one neuoblast (Fig. 8G), whereas 97.4% of type 
II neuroblast lineages were observed with 7±3.4 neuroblasts/lineage (n=38) upon knock 
down of brm (Fig. 8H,K). The neuroblast over-growth phenotype observed upon knock 
down of brm was partially rescued by Brm RNAi-resistant transgene (Fig. 8I, J; 77.8%, 
n=45). This result suggests that loss-of-function of brm causes formation of ectopic 
neuroblasts in type II lineages.  
To confirm the type II-specific neuroblast over-growth phenotype of brm, Mosaic 
Analysis with Repressible Cell Marker (MARCM) analysis was performed on two brm 
loss-of-function alleles, amorphic brm2 and hypomorphic brmT362. Control type I MARCM 
clones contained only one neuroblast that expressed Dpn and Ase (Fig. 9A). Likewise 
type I clones of brm2 (n=22) and brmT362 (n=20) contained only one neuroblast, 
confirming that Brm has no significant role in the regulation of type I neuroblast self-
renewal (Fig. 9B,C). Control type II MARCM clones possessed only one neuroblast that 
expressed Dpn, but not Ase (Fig 9D; n=25). In contrast, 6.4±3.3 and 4.5±2.6 neuroblasts 
were observed in type II clones of brm2 (Fig. 9E,I; 88.6%, n=34) and brmT362 (Fig. 9G,I; 
75.9, n=58) respectively. This phenotype observed in both brm alleles was rescued by 
expressing wild-type Brm transgene (Fig. 9F,H). Taken together, these observations 
indicate that Brm regulates self-renewal of neuroblast specifically in type II lineages.   
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Fig. 8: Knock down of brm results in neuroblast over-growth phenotype in type II 
lineages.  (A-B) Larval brains of control (elav-Gal4 driver; A) and brm knock down (B) 
under the control of elav-Gal4 driver were labeled with Insc (Green) and Mira (red). (C-
D) Larval brains of control (elav-Gal4 driver; C) and brm knock down (D) under the 
control of elav-Gal4 driver were labeled with dMyc (red). (E-F) Larval brains of control 
(‘type I driver’: ase-Gal4; E) and brm knock down (F) under the control of ase-Gal4 were 
labeled with Mira (Red).  (G-J) Type II lineages of control (‘the type II driver’: wor-Gal4, 
ase-Gal80; E), brm knock down (H), RNAi-resistant Brm transgene expression (‘UAS-
BrmRR’; I) and brm knock down rescue (J; UAS-BrmRR; brm RNAi) were labeled with Dpn 
(blue), Ase (red) and CD8 (green). (K) Quantification of neuroblasts number per type II 
lineages for G-H. Arrows indicate neuroblasts. Clones are marked by CD8::GFP and 





Fig. 9: Brm regulates self-renewal of type II neuroblasts. (A-C) Type I MARCM 
clones of control (A), brm2 (B) and brmT362(C) were labeled with Dpn (blue), Ase (red) 
and CD8 (green). (D-H) Type II clones of control (D), brm2 (E, E’), UAS-Brm, brm2 (Brm 
rescue in brm2; F), brmT362 (G, G’) and UAS-Brm, brmT362 (Brm rescue in brmT362; H) 
were labeled with Dpn (blue), Ase (red) and CD8 (green). (I) Quantification of 
neuroblasts number per type II lineages for D, E and G. Arrows indicate neuroblasts. 
Clones are marked by CD8::GFP and indicated by white dotted line. Scale bars, 10μm. 
*** indicates p<0.001. 
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3.2.2 Components of Brm remodeling complex suppress type II neuroblast 
overgrowth 
3.2.2.1 Loss of core complex components of Brm complex results in type II 
neuroblast overgrowth 
Brm, a DNA-dependent ATPase, is the major component of the multi-protein 
SWI/SNF chromatin remodeling complex (Reisman et al, 2009). To determine if the 
regulatory role of Brm in type II neuroblast self-renewal is imparted by its chromatin 
remodeling function, various core components of Brm remodeling complex were 
analyzed. Type II specific knock down of either of the two core components bap60 (Fig. 
10B, D; 5.1±2.8 neuroblasts/lineage, 87%, n=52) or snr1 (Fig. 10C, D; 9.5±5.5 
neuroblasts/lineages, 64.5%, n=34) resulted in varying severity of neuroblast over-
growth phenotype in type II neuroblast lineages. The over-growth phenotype observed 
upon knock down of snr1 was likewise observed in type II MARCM clones of snr1R3 (Fig. 
10F, I; 2.4±1.6 neuroblasts/lineages, 60%, n=30) while all type I clones possessed only 
one neuroblast (Fig. 10K; n=21). In addition, MARCM analysis similarly revealed ectopic 
neuroblasts in type II clones of bap55LL05955 (Fig. 10G, I; 2.3±1.7 neuroblasts/clone, 
30.5%, n=57) and of mor1 (Fig. 10H, I; 3.76±2.23 neuroblasts/lineages, 90.4%, n=21), 
but normal type I clones (Fig, 10L,M; n=20). Together, these observations suggest that 
Brm remodeling complex, at least the core complex, functions to keep the proliferative 








Fig. 10: Core components of Brm complex regulate self-renewal of type II 
neuroblast. (A-C) Type II lineages of control (type II driver; A), bap60 knock down (B) 
and snr1 knock down (C) were labeled with Dpn (blue), Ase (red) and CD8 (green). (D) 
Quantification of neuroblasts number per type II lineages for A-C. (E-H’) Type II MARCM 
clones of control (E), snr1 (F), bap55LL05955 (G, G’) and mor1 (H, H’) were labeled with 
Dpn (blue), Ase (red) and CD8 (green). (I) Quantification of neuroblast number per type 
II clones for E-H’. (J-M) Type I clones of control (J), snr1 (K), bap55LL05955 (L) and mor1 
(M) were labeled with Dpn (blue), Ase (red) and CD8 (green). Arrows indicate 
neuroblasts. Clones are marked by CD8::GFP and indicated by white dotted line. Scale 




3.2.2.2 Loss of osa but not bap180 results in ectopic type II neuroblasts 
Like its mammalian homolog, Drosophila Brm complex could function as two 
different sub-complexes, the Osa containing Brm-Associated Protein (BAP) complex and 
Polybromo/BAP180 containing polybromo associated BAP (PBAP) complex (Biegel et 
al, 2014; Reisman et al, 2009; Trotter and Archer, 2008). These different Brm sub-
complexes were observed to play synergistic or antagonistic functions in regulating gene 
expression in a cell type specific manner (Mohrmann et al, 2004; Reisman et al, 2009). 
To determine the role(s) of these Brm sub-complexes in regulating type II neuroblast 
self-renewal, critical components of the two sub-complexes osa and polybromo were 
analyzed for neuroblast phenotype. Type II specific knock down of osa resulted in 
ectopic type II lineages, each of which with only one neuroblast (Fig. 11B, D; 19.3 type II 
lineages/lobe, 100%, n=16), compared to control that had only eight lineages (Fig. 11A, 
C). MARCM analysis of osa308 revealed mild neuroblast over-growth phenotype in type II 
clones (Fig. 11G; 50%; n=20). Polybromo, on the other hand, was not observed to have 
any significant effect on type II neuroblast self-renewal (Fig. 11E, H). Nonetheless, 
analysis of bap180Δ86 and osa308 double mutants (Fig. 11I, I’; 3.32±2.64 NBs/clone, 
71.6%; n=34) revealed slight but significant enhancement of neuroblasts over-growth in 
type II lineages. These data likely suggest that the BAP and PBAP sub-complex could 










Fig. 11: Roles of BAP and PBAP complex in regulating self-renewal of type II 
neuroblasts. (A-B) Whole brain of control (type II driver; A) and osa knock down (B) 
were labeled with Dpn (blue), Ase (red) and CD8 (green). (C-E) Type II clones of control 
(type II driver; C), osa knock down (D) and bap180 knock down (E) were labeled with 
Dpn (blue), Ase (red) and CD8 (green). (F-H’) Type II MARCM clones of control (F), 
osa308 (G, G’), bap180Δ86 (H, H’) and osa308, bap180Δ86 (I, I’) were labeled with Dpn 
(blue), Ase (red) and CD8 (green). (I-K) Type I clones of control (J), osa308 (K), 
bap180Δ86 (L) and osa308, bap180Δ86 (M) were labeled with Dpn (blue), Ase (red) and 
CD8 (green).  Arrows indicate neuroblasts. Clones are marked by CD8::GFP and 
indicated by white dotted line. Scale bars, 10μm. 
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3.2.2.3 Loss of dMi-2, NURF or ACF complex does not affect type II neuroblast 
self-renewal 
To ascertain if other chromatin remodeling complexes such as dMi-2, 
Nucleosome remodeling factor (NURF) and ATP utilizing chromatin assembly and 
remodeling factors (ACF) complex play similar function in neuroblast self-renewal, key 
components of these complexes were knock down specifically in type II lineages.  RNAi 
knock down of dMi-2, nurf301, iswi or acf1 did not result in any obvious ectopic 
neuroblasts formation (Fig. 12). This result suggests that these other chromatin 
remodeling complexes may not regulate self-renewal of neuroblast in type II lineages, 
though it is possible that RNAi knock down efficiency of these genes may be insufficient 
to cause any observable phenotype. 
 
Fig. 12: Knock down of dMi-2, NURF and ACF complex does not affect type II 
neuroblast self-renewal. (A-D) Type II clones of control (type II driver; A), iswi knock 
down (B), nurf301 knock down (C) and acf1 knock down (D) were labeled with with Dpn 
(blue), Ase (red) and CD8 (green).  Arrows indicate neuroblasts. Clones are marked by 









3.2.3 Brm does not regulate apico-basal cell polarity of neuroblasts 
 Since it is well established that defects in asymmetric cell division can result in 
neuroblast over-growth phenotype (Chang et al, 2012), apico-basal polarity of neuroblast 
was examined. To this end, sub-cellular localization of apical protein, atypical Protein 
Kinase C (aPKC), and basal proteins Numb and Brat were analyzed in 
prometaphase/metaphase neuroblasts of brm2 MARCM clones. Similar to the control 
clones, aPKC was asymmetrically localized at the apical cortex while Numb and Brat 
localized to the basal cortex of neuroblasts in brm2 MARCM clones (Fig. 13). In addition, 
the metaphase DNA of neuroblast in brm2 MARCM clones was positioned perpendicular 
to the apico-basal axis, as revealed by aPKC, Numb or Brat crescent, similar to the 
control clones (Fig. 13). This suggests that Brm does not regulate apico-basal polarity of 






















Fig. 13: Brm does not regulate apico-basal polarity of neuroblasts. (A-F) Neuroblast 
of control MARCM clones and brm2 MARCM clones were labeled with either aPKC 
(white; A, B), Numb (red; C, D) or Brat (red; E, F), CD8 (green) and Phospho-Histone H3 










3.2.4 Brm suppresses de-differentiation of INP back into neuroblast 
3.2.4.1 Loss of Brm complex decreases number of mature INPs and increases 
number of immature INPs 
 A second possible explanation for neuroblast over-growth phenotype is de-
differentiation of INPs back into the neuroblast fate. Upon asymmetric division of type II 
neuroblast, a smaller immature INP is formed (Bello et al, 2008; Boone and Doe, 2008; 
Bowman et al, 2008). This newly formed Ase-negative immature INP undergoes 
maturation, which in the process gains Ase expression. The Ase-expressing late 
immature INP gains Dpn expression and become fully mature with limited proliferative 
capability (Bello et al, 2008; Boone and Doe, 2008; Bowman et al, 2008). The first hint 
on INP de-differentiation is the observation of a reduced mature INP population and 
increased number of immature INPs within type II lineages. In control clones, 18.9±3.7 
INPs (Fig. 14A, A’, G; n=22), which expressed both Dpn and Ase, were observed while 
the number of mature INPs was significantly reduced to 5.3±4.3 in brm2 type II MARCM 
clones (Fig. 14B, B’, G; n=39) and 9.6±4.6 in brmT362 (Fig. 14C, C’, G; n=56). 
Furthermore, the number of immature INPs that expressed PointedP1 (PntP1) but not 
Dpn was upregulated to 8.4±2.5 (Fig. 14E, H; n=26) and 7.1±2.1 (Fig. 14F, H; n=33) in 
brm2 and brmT362 respectively compared to 5.9±1.1 (Fig. 14D, H; n=26) immature INP 
per type II clone in control. Together, these data suggest that INPs de-differentiate back 
into neuroblasts, causing the reduced number of mature INPs and increase in the 







Fig. 14: Loss-of-function of brm results in reduced INP number and increased 
immature INP number. (A-C’) Type II clones of control (A, A’), brm2 (B, B’), and brmT362 
(C, C’) were labeled with Dpn (blue), Ase (red) and CD8 (green). (D-F) Type II clones of 
control (D), brm2 (E) and brmT362 (F) were labeled with Dpn (blue), PntP1 (red) and CD8 
(green). (G) Quantification of NB number per type II clone for A-C’. (H) Quantification of 
immature INP number per type II clone for D-F. White arrows indicate neuroblasts; 
yellow arrows indicate mature INPs; yellow arrowheads indicate immature INPs. Clones 
are marked by CD8::GFP and indicated by white dotted line. Scale bars, 10μm. 
 
Similarly, the number of mature INPs was significantly reduced in mor1 type II 
clones (Fig 15B, B’, E; 8±3.43 INPs/clone; n=21) with 2-fold enhancement in the number 
of immature INPs (Fig. 16F, J; 10.26±2.54 imm. INPs/clone). Type II clones of 
bap55LL5955 and snr1R3 on the other hand showed modest reduction in the number of 
mature INPs (Fig. 15C-E; 13.8±4.1; n=49 and 15±3.7; n=30), although the number of 
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immature INPs was not significantly different from the control (Fig. 16G, H, J). 
Furthermore, knock down of brm (Fig. 16B, J; 7.7±2.2; n=38) or bap60 (Fig. 16C, J; 
11.5±3.9; n=27) caused an increase in the number of Dpn negative and PntP1 positive 
immature INPs, similar to brm2 MARCM clones. Likewise, knock down of osa in type II 
lineages resulted in 19.35±6.66 immature INPs/clone (Fig. 16D, J; n=43) despite the lack 
of neuroblast over-growth within individual type II lineages. Further, the number of 
immature INPs was similar significantly increased in osa308 type II MARCM clones (Fig. 
16I, J; 21.76±6.05 immature INP/clone, n=34). The observed phenotype of osa knock 
down is similar to the reported phenotype of erm (Weng et al, 2010), suggesting sub-
clones formation from primary neuroblast of any of the eight type II lineages. This in turn 
results in the increased number of type II lineages observed upon knock down of osa. 
Altogether, these observations suggest that loss of Brm complex affects INP formation, 












Fig. 15: Loss of core components of Brm complex results in modest reduction in 
mature INP population. (A-D) type II MARCM clones of control (A), mor1 (B, B’), 
bap55LL05955 (C, C’) and snr1R3 (D, D’) were labeled with Dpn (blue), Ase (red) and CD8 
(green). (E) Quantification of number of mature INPs per type II clone for A-D. White 
arrows indicate neuroblasts, yellow arrows indicate mature INPs, and yellow arrowheads 
indicate immature INPs. Clones are marked by CD8::GFP and indicated by white dotted 









Fig. 16: Loss of core components of Brm complex results in increased number of 
immature INPs. (A-D) type II clones of control (type II driver; A), brm knock down (B), 
bap60 knock down (C) and osa knock down (D) were labeled with Dpn (blue), PntP1 
(red) and CD8 (green). (E-I) type II MARCM clones of control (E), mor1 (F), bap55LL05955 
(G), snr1R3 (H) and osa308 (I) were labeled with Dpn (blue), PntP1 (red) and CD8 (green). 
(J) Quantification of the number of immature INPs per type II clone for A-I. White arrows 
indicate neuroblasts, yellow arrows indicate mature INPs, and yellow arrowheads 
indicate immature INPs. Clones are marked by CD8::GFP and indicated by white dotted 









3.2.4.2 Loss of brm results in de-differentiation of INP back into neuroblast 
To determine if Brm indeed suppresses de-differentiation of INP, brm was 
specifically knocked down in INP using 2 copies of erm-Gal4 (erm-Gal4 (II); erm-Gal4 
(III); henceforth referred to as INP driver). In control INP clones, neuroblast was observed 
immediately adjacent to and outside of the clone (Fig. 17A; 0 NB/clone; n=53), whereas 
knock down of brm resulted in the appearance of neuroblasts within INP clones (Fig. 
17B, B’; 1.2±1.6 NB/clone; 42.5%, n=40). This result demonstrates that Brm indeed 


















Fig. 17: Knock down of brm in INP results in reversion of INP back into neuroblast. 
(A-C) INP clones of control (erm-Gal4 (II); erm-Gal4 (III), INP driver; A) and brm knock 
down under the control of INP driver were labeled with Dpn (blue), Ase (red) and CD8 
(green). Arrows indicate neuroblasts. Clones are marked by CD8::GFP and indicated by 









3.2.5 HDAC3 functions synergistically with Brm complex to regulate type II 
neuroblast self-renewal  
Besides chromatin remodeling, epigenetics also involves post-translational 
modification of histones. This includes histone acetylation, methylation, phosphorylation, 
ubiquitination, sumolyation and various others (Bannister and Kouzarides, 2011). Given 
that Brm chromatin remodeling complex was identified to regulate neuroblast 
homeostasis, it is therefore interesting to determine if any of the histone modifiers in 
Drosophila play similar regulatory function.  
To assess whether histone modification similarly regulates type II neuroblast self-
renewal, I screened a collection of 48 histone modifiers (Table 2) by transgenic RNAi 
knock down in type II lineages, however, to no avail. Knock down of various histone 
modifiers did not cause any observable over-growth phenotype (data not shown). The 
lack of phenotype could be accounted by the fact that histone modification function 
synergistically with chromatin remodeling. As such, RNAi screen was re-performed 
under the background of brm knock down driven by insc-Gal4. Interestingly, knock down 
of hdac3 in brm knock down background resulted in significant neuroblast over-growth 
phenotype as demonstrated by the increased population of Mira positive cells (Fig. 18A, 
B). Consistently, double knock down of brm and hdac3 (Fig. 18F, G; 22.1±7.4 
NBs/clone, n=21) by the type II driver resulted in two-fold enhancement of the neuroblast 
over-growth phenotype of brm single knock down (Fig. 18D, G; 10.3±5.6 NBs/clone, 
n=30). Single knock down of hdac3, however, did not cause any obvious neuroblast 





Fig. 18: hdac3 genetically interacts with brm to suppress neuroblast over-growth 
in type II lineages. (A-B) whole brains of brm knock down (A) and brm and hdac3 
double knock down were labeled with mira (red). (C-F) Type II clones of control (type II 
driver; C), brm knock down (D), hdac3 knock down (E) and brm and hdac3 double knock 
down were labeled with Dpn (blue), Ase (red) and CD8 (green). Arrows indicate 
neuroblasts. Clones are marked by CD8::GFP and indicated by white dotted line. Scale 
bars, 10μm. 
 
To ascertain if the genetic interaction between brm and hdac3 can similarly be 
observed between hdac3 and other components of Brm remodeling complex, MARCM 
analysis of snr1 and hdac3 double mutant was performed. Snr1 and HDAC3 gene loci 
are located adjacent to each other on the right arm of third chromosome. P element 
excision experiment conducted in a previous study generates a deletion mutant with the 
entire snr1 coding region and C terminal region of hdac3 gene deleted (Zhu et al, 2008). 
MARCM analysis of this double mutant revealed severe neuroblast over-growth 
phenotype in type II clones (Fig. 19D, I; 22±11.5, 83.0%, n=22) while type I clones were 
normal with only one neuroblast (Fig. 19H). This is in contrast to the mild type II 
neuroblast over-growth phenotype of snr1R3 (Fig. 19C, I; 2.4±1.6; 61.3%, n=31) and 
completely normal type II clones of hdac3N (Fig. 19B, I; n=21). Of significant interest, 
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neuroblast over-growth of snr1 hdac3 clones persisted into the adult fly stages, causing 
the generation of massive number of Dpn positive neuroblasts in the adult brain while no 
neuroblast was observed in the control (Fig. 19J, K). Together, these data imply that 
HDAC3 acts synergistically with Brm complex to regulate type II neuroblast 
homeostasis. 
 Fig. 19: hdac3 genetically interacts with snr1 to suppress neuroblast over-growth 
in type II lineages. (A-D) Type II clones of control (A), hdac3N (B), snr1R3 (C) and snr16C 
hdac36C (D) were labeled with Dpn (blue), Ase (red) and CD8 (green). (E-H) Type I 
clones of control (E), hdac3N (F), snr1R3 (G) and snr16C hdac36C (H) were labeled with 
Dpn (blue), Ase (red) and CD8 (green). (I) Quantification of NB number per type II clone 
for A-D. (J-K) MARCM clones in adult fly brain of control (J) and snr16C hdac36C (K) were 
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labeled with Dpn (blue), PH3 (red) and CD8 (green). Arrows indicate neuroblasts. 
Clones are marked by CD8::GFP and indicated by white dotted line. Scale bars, 10μm. 
 
3.2.6 The Brm remodeling complex physically associates with Erm and HDAC3  
3.2.6.1 Brm physically associates with Erm 
Given the ubiquitous expression of Brm in larval brain, the type II specific 
function observed for this epigenetic regulator suggests co-functioning with a cell type 
specific factor. To date, there are two type II specific transcription factors, ETS domain 
containing PointedP1 (PntP1) and the zinc finger transcription factor Earmuff (Erm). 
PntP1, which is expressed in type II neuroblast and immature INPs, suppresses Ase 
expression in neuroblast and confer its identity. In addition, PntP1 potentially regulated 
downstream INP formation (Zhu et al, 2012). Erm on the other hand is expressed in 
INPs where it induces differentiation and prevent de-differentiation (Weng et al, 2010).  
To determine if either PntP1 or Erm functions as a co-factor for Brm complex, co-
immunoprecipitation (Co-IP) was performed. However, since full length Erm could not be 
stably expressed at a sufficiently high level in S2 cells, two truncated proteins, Erm N-
terminal 1-441 amino acids (Erm-N) that contains first four of the six zinc finger domains 
and Erm C-terminal 332-611 amino acids (Erm-C) that contains the last four of the six 
zinc finger domains, were generated and used for subsequent Co-IP experiments (Fig. 
20A). Myc-tagged Brm was co-transfected with either Flag-tagged Erm-N or Erm-C in S2 
cells. Upon immunoprecipitation (IP) of Flag-Erm-N or Erm-C, Myc-Brm was detected in 
the immune complexes (Fig. 20B). In contrast, Myc-Brm was not detected upon IP with 
Flag-PntP1 (Fig. 20C). To confirm this specific interaction between Brm and Erm, 
Maltose-Binding Protein (MBP) protein pull-down assays were performed. Truncated 
MBP-Erm-N or MBP-Erm-C fusion protein was expressed in BL21 E.coli strain and 
bound to amylose resin. The MBP-Erm-N or MBP-Erm-C bound amylose resin was 
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subsequently incubated with protein extracts of S2 cells expressing Myc-Brm. Following 
pull down, Myc-Brm was observed to strongly associate with MBP-Erm-N and weakly 
with MBP-Erm-C, but not with MBP alone (Fig. 20D). Together, these data demonstrate 
that Brm physically associates with Erm as a protein complex, but not with PntP1. This 
suggests the involvement of Erm as a co-factor for Brm complex to confer its cell-type 
specific function in type II lineages.  
Fig. 20: Brm physically interacts with Erm. (A) Schematic illustration of Erm domains 
and truncated constructs. (B) Co-IP between Myc-Brm and Flag-Erm-N or Flag-Erm-C. 
(C) Co-IP between Myc-Brm and Flag-PntP1. Co-IP was performed using S2 cells 
expressing the various tagged proteins. IP was performed using anti-Flag or anti-Myc 
antibodies. Western blot was performed using anti-Flag and anti-Myc antibodies. (D) 
Protein pull-down assay. MBP, MBP-Erm-N and MBP-ErmC bound beads were 
incubated with protein extracts from S2 cells expressing Myc-Brm. Western blot was 
performed using an anti-Myc antibody. Coomassie blue (CB) staining showed 10% input 
of various purified MBP or MBP fusion proteins. 
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Fig. 21: Bap60 and Snr1 physically interact with Erm. (A) Co-IP between Flag-Bap60 
and Myc-Erm-N or Myc-Erm-C. (B) Co-IP between Myc-Snr1 and Flag-Erm-N or Flag-
Erm-C. Co-IP was performed using S2 cells expressing the various tagged proteins. IP 
was performed using anti-Flag or anti-Myc antibodies. Western blot was performed using 
anti-Flag and anti-Myc antibodies. (C) Protein pull-down assay. MBP, MBP-Erm-N and 
MBP-ErmC bound beads were incubated with protein extracts from S2 cells expressing 
Myc-Snr1 or Flag-Bap60. Western blot was performed using an anti-Myc antibody. 








3.2.6.2 Snr1 and Bap60 physically associates with Erm 
 Next, to ascertain if other components of the Brm complex could similarly interact 
with Erm, I performed Co-IP experiments in a similar set up for Bap60 or Snr1 with Erm-
N or Erm-C. In these Co-IP experiments, Flag-Bap60 was detected in the immune 
complex following IP with Myc-Erm-N but not with Myc-Erm-C (Fig. 21A). Myc-Snr1 was 
likewise detected in the immune complex following IP by Flag-ErmN (Fig. 21B). 
Consistently, physically interaction was observed between Flag-Bap60 and Myc-Snr1 
with MBP-Erm-N in protein pull down assays (Fig. 21C). Taken together, these data 
imply that Brm complex, or at least several core components namely Brm, Bap60 and 
Snr1, physically associate with Erm.  
 
3.2.6.3 Bap180 but not Osa interacts physically with Erm 
To determine which Brm sub-complexes associate with Erm, Co-IP experiments 
between Osa or Polybromo with Erm-N and Erm-C were performed. Myc-Polybromo 
was observed in the immune complex when IP with Flag-Erm-N but not Flag-Erm-C (Fig. 
22B). Myc-Osa on the other hand did not physically associate with both Erm-N and Erm-
C, despite its interaction with Brm (Fig. 22A). Consistently, Myc-Bap180 but not Myc-
Osa was pulled down by MBP-Erm-N (Fig. 22C). These observations suggest that the 
polybromo-containing PBAP complex, but not the osa-containing BAP, likely form a 







Fig. 22: Bap180 but not Osa physically interacts with Erm. (A) Co-IP between Myc-
Osa and Flag-Erm-N or Flag-Erm-C. (B) Co-IP between Myc-Bap180 and Flag-Erm-N or 
Flag-Erm-C. Co-IP was performed using S2 cells expressing the various tagged 
proteins. IP was performed using anti-Flag or anti-Myc antibodies. Western blot was 
performed using anti-Flag and anti-Myc antibodies. (C) Protein pull-down assay. MBP, 
MBP-Erm-N and MBP-ErmC bound beads were incubated with protein extracts from S2 
cells expressing Myc-Osa or Myc-Bap180. Western blot was performed using an anti-
Myc antibody. Coomassie blue (CB) staining showed 10% input of various purified MBP 







3.2.6.4 HDAC3 interacts physically with Brm and Erm  
 Since HDAC3 function synchronously with Brm complex to regulate neuroblast 
self-renewal in type II lineages, it is likely that HDAC3 associates physically with Brm. To 
test this hypothesis, Co-IP experiment was performed using protein extract of S2 cells 
co-expressing Flag-HDAC3 and Myc-Brm. Flag-HDAC3 was detected in the immune 
complex following IP with Myc-Brm (Fig. 23A). Since Brm could associate with Erm as a 
protein complex, I next ascertained if HDAC3 could similarly interact with Erm-N or Erm-
C in Co-IP and MBP protein pull-down assay. Indeed, HDAC3 was also observed to 
physically interact with Erm-N but not with Erm-C in both Co-IP and MBP pull down 
assays (Fig. 23B, C). This result demonstrates that Brm physically associates with Erm 



















Fig. 23: HDAC3 physically associates with Brm and Erm. (A) Co-IP between Flag-
HDAC3 and Myc-Brm. (B) Co-IP between Myc-HDAC3 and Flag-Erm-N or Flag-Erm-C. 
Co-IP was performed using S2 cells expressing the various tagged proteins. IP was 
performed using anti-Flag or anti-Myc antibodies. Western blot was performed using 
anti-Flag and anti-Myc antibodies. (C) Protein pull-down assay. MBP, MBP-Erm-N and 
MBP-ErmC bound beads were incubated with protein extracts from S2 cells expressing 
Myc-HDAC3. Western blot was performed using an anti-Myc antibody. Coomassie blue 





3.2.7 Brm complex genetically interacts with Erm to regulate homeostasis of type 
II neuroblasts 
3.2.7.1 Brm and Snr1 genetically interacts with Erm  
 Given that various core components of Brm complex physically associated with 
Erm, I next ascertained if brm and erm genetically interact to suppress the formation of 
ectopic type II neuroblasts in larval brain. To this end, I assessed if loss-of-function of 
erm could enhance the neuroblast over-growth phenotype of brm. Knock down of erm by 
RNAi in type II neuroblast resulted in the formation of ectopic number of type II lineages 
per brain hemisphere (Fig. 24 G, H). However, no ectopic neuroblasts were observed 
within each lineage upon knock down of erm (Fig. 24C, I). This observation is consistent 
with the previous report that de-differentiated neuroblasts can establish ectopic II 
lineages or sub-clones originating from a primary clone of erm- mutant (Weng et al, 
2010). Interestingly, concomitant knock down of erm and brm resulted in approximately 
four times enhancement in the number of ectopic neuroblasts in each type II lineage 
(Fig. 24D, I; 37.1±7.6 neuroblasts/lineage, n=20) compared to knock down of brm alone 
(Fig. 24B, I; 9.5±2.8, n=32). Consistently, knock down of erm in type II MARCM clones of 
brmT362 (Fig 24F, F’, J; 9.9±5.5 neuroblasts/clone, n=32) resulted in significant 
enhancement of the neuroblast over-growth phenotype of brmT362 clones (Fig. 24E, E’, J; 
4.1±2.4 neuroblasts/clone, n=30). These observations suggest that brm genetically 
interacts with erm to regulate self-renewal of type II neuroblast.  
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Fig. 24: brm genetically interacts with erm to suppress neuroblast over-growth in 
type II lineages. (A-D) Type II clones of control (type II driver; A), brm knock down (B), 
erm knock down (C) and brm and erm double knock down were labeled with Dpn (blue), 
Ase (red) and CD8 (green). (E-F) Type II MARCM clones of brmT362(E, E’) and erm 
knock down in brmT362 (F, F’) were labeled with Dpn (blue), Ase (red) and CD8 (green). 
(G-H) Whole brains of control (G; type II driver) and erm knock down (H) were labeled 
with Dpn (blue), Ase (red) and CD8 (green). (I) Quantification of neuroblast number per 
type II lineages for A-D. (J) Quantification of neuroblasts number per type II MARCM 
clone for E-F. Arrows indicate neuroblasts. Clones are marked by CD8::GFP and 





































Fig. 25: brm suppresses premature differentiation induced by ectopic expression 
of Erm. (A-D) Type II MARCM clone of brm2 (A, A’), Erm over-expression (B-C) and Erm 
over-expression in brm2 (D-E) were labeled with Dpn (blue), Ase (red) and CD8 (green). 
Arrows indicate neuroblasts. Clones are marked by CD8::GFP and indicated by white 
dotted line. Scale bars, 10μm.  
 
Given that ectopic expression of Erm in type II lineages results in premature 
differentiation of neuroblast (Weng et al, 2010), I tested whether this function is 
dependent on Brm. Consistent with previous report (Weng et al, 2010), ectopic 
expression of Erm in type II MARCM clones resulted in premature differentiation of 
neuroblast that occurred in full penetrance (Fig. 25B, C; n=41) with 70.8% of the clones 
containing neuroblast that expressed Ase, and the remaining clones without any 
observable neuroblast. In contrast, ectopic expression of Erm in type II MARCM clones 
of brm2 resulted in premature differentiation of neuroblast in only 62.2% of clones (Fig. 
25D; n=37) while the remaining 37.8% of clones exhibited neuroblast over-growth 
phenotype (Fig. 25E; n=37). This suppression observed suggests that premature 
differentiation induced by Erm over-expression is dependent on its association with Brm. 
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Furthermore, simultaneous knock down of erm and snr1 in type II lineages 
caused more severe neuroblast over-growth phenotype (Fig. 26D, E; 862±106.8 
neuroblasts/brain lobe, n=20), in contrast to single knock down of either erm (Fig. 26B, 
E; 76.6±14.2 neuroblasts/brain lobe, n=20) or snr1 alone (Fig. 26C, E; 219.5±52.2 
neuroblasts/brain lobe, n=20).  This result suggests that snr1 and erm genetically 
interact to suppress the formation of ectopic neuroblasts, much similar to that observed 



















Fig. 26: snr1 genetically interacts with erm to regulate self-renewal of type II 
neuroblasts. (A-D) whole brains of control (elav-Gal4 driver; A), erm knock down (B), 
snr1 knock down (C) and snr1 and erm double knock down were labeled with Dpn 
(blue), Ase (red) and Mira (green). (E) Quantification of type II neuroblast number per 




3.2.7.2 Loss of notch partially suppresses type II neuroblast overgrowth of brm 
Loss of notch activity could partially suppress neuroblast over-growth phenotype 
of erm- (Weng et al, 2010). To test if loss of notch could similarly suppress formation of 
ectopic neuroblasts in brm, double knock down of notch and brm was performed. Similar 
to the reported suppression of erm phenotype by notch, knock down of notch 
suppressed neuroblast over-growth to 6.0±4.0 NBs/clone (Fig. 27C, D; n=76). Whereas 
single knock down of brm resulted in 10.8±4.7 NBs/clone (Fig. 27B, D; n=39) and knock 
down of notch caused loss of type II neuroblast (Fig. 27A, D; n=39). This result is 
consistent with the hypothesis that Brm and Erm co-function as a complex to regulate 
type II neuroblast homeostasis. 
 
Fig. 27: Knock down of notch partially suppresses neuroblast over-growth of brm. 
(A-C) Type II clones of notch knock down (A), brm knock down (B) and notch and brm 
double knock down were labeled with Dpn (blue), Ase (red) and CD8 (green). (D) 
Quantification of neuroblast number per type II clone for A-C. Arrows indicate 












3.2.8 HDAC3 genetically interacts with Erm to suppress ectopic formation of 
neuroblasts in type II lineages 
 The earlier observations that HDAC3 genetically and physically interacts with 
Brm support the hypothesis that HDAC3 and Brm function synergistically to regulate 
neuroblast homeostasis. Next, I performed genetic analysis to ascertain the functional 
relevance of the physical association between HDAC3 and Erm. To this end, hdac3 was 
simultaneously knocked down with erm in type II neuroblast lineages. While knock down 
of erm alone resulted in 76.0±7.7 type II neuroblasts/brain hemisphere (Fig. 28B, D; 
n=20), simultaneous knock down of erm and hdac3 resulted in 565.4±68.1 type II 
neuroblasts/brain hemisphere (Fig. 28C, D; n=20) despite the lack of observable over-
growth phenotype upon knock down of hdac3 alone (Fig. 28D). This data implies that 
hdac3 genetically interacts with erm to suppress formation of ectopic neuroblasts. 
 
Fig. 28: hdac3 genetically interacts with erm to inhibit type II neuroblast over-
growth. (A-C) whole brains of control (type II driver; A), erm knock down (B) and erm 
and hdac3 double knock down were labeled with Dpn (blue), Ase (red) and CD8 (green). 
(D) Quantification of type II neuroblast number per brain hemisphere for A-C. Arrows 
indicate neuroblasts. Clones are marked by CD8::GFP and central brain is to the left of 







3.2.9 Brm and HDAC3 genetically interacts with PntP1 to regulate INP formation 
PointedP1 is an ETS domain transcription factor that regulates type II neuroblast 
fate partly through suppression of Ase expression in neuroblast (Zhu et al, 2012). In 
addition to its expression in type II neuroblast, PntP1 is also expressed in immature INPs 
and is hypothesized to play a regulatory role in INP formation (Zhu et al, 2012). In brm 
mutant or knock down, the number of PntP1 expressing cells, either neuroblasts or 
immature INPs, was increased (Fig. 14D-H and Fig. 16B, J). To determine if increased 
expression of PntP1 was responsible for the neuroblast over-growth phenotype of brm, 
pntp1 was simultaneously knock down with brm in type II lineages. Surprisingly, double 
knock down of brm and pntp1 resulted in severe neuroblast over-growth compared to 
brm single knock down (Fig. 29A-H). Single knock down of pntp1 on the other hand 
caused Ase expression in type II neuroblast with reduction in the number of progenitor 













Fig. 29: brm genetically interacts with pntP1 to regulate self-renewal of type II 
neuroblasts. (A-D) Type II clones of control (type II driver; A), brm knock down (B), pnt 
knock down (C) and brm and pnt double knock down were labeled with Dpn (blue), Ase 
(red) and CD8 (green). (E-H) Whole brains of control (type II driver; E), brm knock down 
(F), pnt knock down (G) and brm and pnt double knock down were labeled with Dpn 
(blue), Ase (red) and CD8 (green). Arrows indicate neuroblasts. Clones are marked by 
CD8::GFP and indicated by white dotted line. Scale bars, 10μm. 
 
Likewise, removing one copy of functional Pnt gene in homozygous brm2 mutant 
clones resulted in 10.0±5.1 NB/clone (Fig. 30C, E; n=42) while 6.4±3.9 NBs/clone (Fig. 
30B, E; n=34) was observed for brm2 clones. Further, hdac3N and pntΔ88 double mutant 
clones showed mild neuroblasts over-growth phenotype (Fig. 30D, D’; 93%, n=15) while 
only one neuroblast was observed in hdac3N type II clones (Fig. 19B, I; n=21). This 
evidence suggests that brm and hdac3 genetically interacts with pntp1 during INP de-
differentiation. This also points to an unexpected novel function for PntP1 in suppressing 






Fig. 30: brm and hdac3 genetically interact with pntP1 to regulate type II 
neuroblast self-renewal. (A-D) Type II MARCM clones of control (A), brm2 (B), +/pntΔ88; 
brm2 (C) and hdac3N pnt Δ88 double mutant (D, D’) were labeled with Dpn (blue), Ase 
(red) and CD8 (green). (E) Quantification of neuroblast number per type II clones for A-
C. Arrows indicate neuroblasts. Clones are marked by CD8::GFP and indicated by white 


















4.1 Brm complex regulates neuroblast homeostasis through suppression of INP 
de-differentiation 
In this thesis, I report that loss-of-function of brm resulted in formation of ectopic 
neuroblast in type II lineages in Drosophila. Mutants of the other core components of 
Brm complex, including bap55, snr1 and moira, and RNAi knock down of bap60 resulted 
in ectopic neuroblasts in type II lineages. Together, this body of evidence suggests that 
Drosophila Brm chromatin remodeling complex plays a tumor-suppressor role in the type 
II neuroblast lineages. Further, intrinsic asymmetric division machinery was not affected 
as inferred from the normal asymmetric localization of aPKC, Numb and Brat, and 
proper spindle orientation. Rather, the number of mature INPs was reduced upon the 
loss-of-function of Brm complex whereas the number of immature INPs was increased. 
These suggest the possibility that INPs undergo de-differentiation back to neuroblast 
fate. Indeed, knock down of brm specifically in INPs resulted in the formation of 
neuroblasts within INP clones while a primary neuroblast was always observed outside 
of the control INP clones. In conclusion, Drosophila Brm complex suppresses de-























Fig. 31: Proposed model for the function of Brm chromatin remodeling complex. 
Brm complex physically associates with HDAC3 and Erm as a protein complex. This 
novel protein complex suppresses de-differentiation of immature INPs. 
 
4.2: Earmuff confers the type II neuroblast specific functions of the ubiquitous 
Brm complex. 
Brm is ubiquitously expressed in all cell types to regulate gene expression. In the 
mammalian system, Brahma chromatin remodeling complex was reported to possess 
cell type specific functions through interaction with zinc finger transcription factor 
(Kadam and Emerson, 2003). As such, observation of cell type specific functions of Brm 
complex in the immature INPs of the type II neuroblast lineages suggests regulation of 
its function by cell specific transcription factor. Indeed, several core components of Brm 
complex, including Brm, Snr1 and Bap60 physically associated with the type II specific 
transcription factor, Erm, in vitro. Furthermore, genetic interaction between Brm or Snr1 
110 
 
with Erm revealed a physiological implication for this novel protein complex. 
Simultaneous knock down of erm with snr1 or brm enhanced neuroblast over-growth 
phenotype of either single knock down. In addition, the premature differentiation of type 
II neuroblasts induced by ectopic expression of Erm was suppressed by loss-of-function 
of brm, which further suggests that Brm and Erm co-function as a complex. Furthermore, 
neuroblast over-growth phenotype of brm knock down could be partially suppressed by 
knock down of notch, which is similar to the suppression observed for erm- when notch 
is loss (Weng et al, 2010). Taken together, this body of evidence suggests that Erm 
functions as a co-factor of Brm remodeling complex to confer its INP specific functions.  
Nonetheless, it is uncertain how this novel protein complex could suppress de-
differentiation of INPs in type II neuroblast lineages. One possibility is that the Brm-Erm 
complex confers a unique ‘chromatin landscape’ in INPs to restrict its proliferative ability 
and prevent de-differentiation. Bioinformatics analysis by our collaborator identified a 
14bp-long DNA-binding motif of Erm, which co-occupies at a significantly high frequency 
of 74.8% with the known Brm binding positions (analysis done by our collaborators 
Zhizhuo Zhang and Wing-Kin Sung) (Negre et al., 2011; Koe et al., 2014) in Drosophila 
genome. However, quantitative-PCR analysis of these potential targets did not reveal 
any consistent significant alteration to their expression upon the knock down of brm 
(Appendix 1).  One potential explanation for the lack of altered expression is the lack of 
purity of cell types within larval brains used for Q-PCR. Larval brains contain a mixed cell 
population that includes neuroblasts, INPs, GMCs and huge number of. As such, even if 
there is altered expression of the downstream targets, it would have been masked by the 
normal expression in the other cell types. Another possible explanation is that the known 
Brm binding sites used in bioinformatics analysis is not an accurate representation of 
genes regulated by Brm in INPs. The published Brm binding sites were determined from 
Chromatin immunoprecipitation (ChIP) experiments performed on pupae (Negre et al., 
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2011). In response to the systemic ecdysone pulses, Drosophila larvae undergo 
pupation during which it goes through major re-structuring of its body. Thus, it is likely to 
have significant differences in the epigenetic marks within cells before and after 
pupation. It is likely that binding sites of Brm during pupal stage differ dramatically from 
those in INPs.  
 
4.3: Dynamic functioning of Brm complex in type II neuroblast lineages 
While it is evident that core components of Brm complex associate with Erm to 
suppress de-differentiation of INPs, it is less certain which sub-complex is involved. 
Loss-of-function of osa resulted in expanded population of immature INPs with mild 
neuroblast over-growth phenotype, suggesting possible involvement of the BAP complex 
in regulating type II neuroblast homeostasis. However, Osa did not associate with Erm 
physically. Polybromo on the other hand physically associated with Erm. However, loss-
of-function of polybromo did not result in neuroblast over-growth phenotype. This lack of 
phenotype in bap180Δ86 could potentially be due to its functional redundancy with 
another PBAP component, Bap170 (Carrera et al, 2008). In contrast to the mild 
phenotype of osa308 single mutant and normal type II type II neuroblast clones of 
bap180Δ86, bap180Δ86 and osa308 double mutant showed severe neuroblast over-growth 
phenotype. Potentially, the BAP and PBAP sub-complex could function synergistically to 
regulate neuroblast homeostasis in type II lineages. Notably, despite the mild neuroblast 
over-growth phenotype, the number of immature INPs within type II clones upon loss of 
osa is more severe than loss of other Brm complex components. Loss-of-function of 
bap55 and snr1 resulted in mild neuroblast over-growth, however, both showed almost 
normal immature INP population. Based on these observations, it seems likely that the 
population of reverted immature INPs upon loss of osa is not able to fully revert back to 
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neuroblast fate. As such, it is possible that the Osa-containing BAP complex functions at 
later stage in INP formation or maintenance. Indeed, Osa containing BAP complex was 
recently demonstrated to regulate the timely exit of INPs from the proliferative state and 
ensure temporal patterning of INPs in a Hamlet dependent manner (Eroglu et al., 2014). 
Loss-of-function of hamlet was reported to result in ectopic INPs within type II lineages 
without neuroblast over-growth (Eroglu et al., 2014). It is therefore possible that the BAP 
complex functions at a slightly later developmental stage to regulate INP homeostasis as 
a separate complex without Erm. PBAP on the other hand might associate with Erm as a 
complex, potentially to prevent INP de-differentiation during the maturation of INPs. 
Future analysis is required to test this hypothesis. It is possible that the Brm complex 
functions dynamically in type II neuroblast lineages in a temporal fashion as depending 
































Fig. 32:  Proposed model for the dynamic functioning of Brm remodeling complex 
in type II neuroblast lineages. Bap180 physically associates with Erm and could 
potentially function with HDAC3 and Erm to suppress de-differentiation of immature 
INPs; however, this requires further analysis. Osa-containing BAP on the other hand 
functions at a later stage to regulate INP homeostasis. 
 
4.4: HDAC3 functions synergistically with Brm complex and Erm to suppress 
formation of ectopic neuroblasts 
 Members in class I HDAC are ubiquitously expressed in most cell types and are 
nuclear localized (Ropero and Esteller, 2007). They are often recruited into large 
multimeric co-repressor complexes for maximal activity. In particular, HDAC3 is uniquely 
recruited and functions in the Silencing mediator of retinoic and thyroid receptors 




In this thesis, I demonstrate that the Drosophila HDAC3 functions synergistically 
with the Brm chromatin remodeling complex to regulate neuroblast homeostasis in type 
II lineages. Loss-of-function of hdac3 dramatically enhanced neuroblast over-growth 
phenotype of brm or snr1. Further, HDAC3 physically associated with Brm and Erm as a 
novel complex in vitro. Knock down of hdac3 significantly enhanced neuroblast over-
growth phenotype of erm, which is similar to its epistatic relationship with Brm and Snr1. 
Together, these data infer that HDAC3 associates with a novel multimeric complex 
comprising of Brm and Erm to prevent de-differentiation of INPs back into type II 
neuroblasts in the Drosophila.  
Given that HDAC3 is known to interact and function with the SMRT/NCoR 
complex (Guenther et al., 2000; Li et al., 2000), it is possible that the Brm-HDAC3-Erm 
complex co-functions with SMRT/N-CoR complex to repress gene expression. 
Furthermore, in the mammalian system, HDAC3 together with its associating nuclear 
receptor corepressor complex (NCoR) was observed as a protein complex with the 
mammalian SWI/SNF complex (Underhill et al, 2000). However, transgenic RNAi knock 
down of smrter that encodes a core component of the SMRT complex (Heck et al, 2012) 
did not result in the formation of ectopic type II neuroblasts and it also did not interact 
genetically with brm (Koe et al, 2014; data not shown). This likely suggests that the Brm-
HDAC3-Erm complex functions independent of SMRT/NCoR complex (Fig. 31). 
 Consistent with the observed interaction between HDAC3 and BRG1 in the 
mammalian system, the physical and genetic interactions observed between Drosophila 
HDAC3 with Brm and Erm suggest that the Brm-HDAC3-Erm complex likely functions as 





4.5 Significances of the tumor suppressor role of the Brm-HDAC3-Erm repressor 
complex in human cancers 
Several subunits of the human SWI/SNF complex are associated with various 
human cancers. Deletion of the bona fide tumour suppressor BAP47, human homolog of 
the Drosophila Snr1, is associated with the development of pediatric rhabdoid tumors 
(Reisman, 2009). Mutations in other components of human SWI/SNF complex including 
BRG1 and BRM are also implicated in hepatocellular carcinoma, bladder cancer, 
medulloblastoma, leukemia and lymphoma (Reismann, 2009). Furthermore, reduced 
SWI/SNF activity due to loss of Brg1/Brm is frequently associated with tumor 
progression and poor prognosis in non-small cell lung carcinoma, gastric cancer and 
squamous cell carcinomas. (Weissman and Knudsen, 2009; Gui, Guo et al. 2011; 
Fujimoto, Totoki et al. 2012; Pugh, Weeraratne et al. 2012). Among which, several 
human cancers are found to likely involve de-differentiation of differentiated progenitor 
cells including glioblastoma (Friedmann-Morvinski 2014; Friedmann-Morvinski and 
Verma 2014). As such, the data presented here could provide mechanistic insights into 
several types of human cancers in which mutations or deletion of human SWI/SNF 
complex components are implicated. Potentially, in those cancer types, de-differentiation 
of differentiated cells could be the source of subverted cancer stem cells. Further 
analysis is required to identify the cancer stem cells and its source. Currently, de-
differentiation was observed upon ectopic expression of oncogenes like Ras and Myc in 
differentiated cells, which provide the proliferative signal to divide (Friedmann-Morvinski 
2014; Friedmann-Morvinski and Verma 2014). However, the precise molecular 
mechanism that underlies reversal of the differentiation program or suppression of de-
differentiation is unknown. Potentially, the Brm-HDAC3-Erm complex could regulate 
multiple genes in a genome-wide scale to control the balance between self-renewal and 
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differentiation. However, it is also possible that there exist a key downstream target that 
regulates de-differentiation. Thus, it would be interesting to determine the downstream 
targets of the Brm-HDAC3-Erm complex to understand how de-differentiation occurs.  
Such understanding into the mechanism of de-differentiation could also identify 
targets for therapeutics treatment of human cancers. Several recent studies revealed 
that the residual activity of SWI/SNF complex in cancers with mutation in SWI/SNF 
components is required for the ectopic proliferation of cancer cells (Hohmann and 
Vakoc, 2014). Further, in some non-SWI/SNF mutant cancers, inactivation of SWI/SNF 
could inhibit tumor growth (Hohmann and Vakoc, 2014). Thus, SWI/SNF is a good 
candidate for anti-cancer therapy. However, SWI/SNF activity is also necessary for 
many normal cellular functions. As such, inhibiting SWI/SNF activity as a cancer 
treatment could result in numerous severe side effects. Alternatively, identifying key 
downstream targets of SWI/SNF could potentially provide good targets for cancer 
treatment. Thus, identifying the downstream targets of the Brm-HDAC3-Erm complex in 
Drosophila could serve as a good starting point to identify such targets.   
HDACs are typically recruited by oncogenic protein complexes or are ectopically 
expressed in various human cancers (Ropero and Esteller, 2007). Therefore, HDAC 
inhibitors are often used synergistically with anticancer agents for therapeutics 
(Dokmanovic, Clarke et al. 2007). On the contrary, Ropero and co-workers reported that 
loss of HDAC2 expression and function is associated with tumors with microsatellite 
instability and in hereditary non-polyposis colorectal carcinoma (Ropero, Fraga et al. 
2006). Ectopic expression of HDAC2 inhibits tumor growth in xenograft nude mice 
(Ropero, Fraga et al. 2006), further suggesting a tumor suppressor role of HDAC2. 
Interestingly, in this thesis, HDAC3 was demonstrated to function cooperatively with Brm 
complex in suppressing de-differentiation of INPs into neuroblasts, revealing an 
unexpected potential involvement of HDAC3 in tumor suppression in brain tissue. 
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Therefore, it will be of interest to determine whether the tumor suppressor functions of 
Drosophila HDAC3 reported here is conserved in the mammalian central nervous 
system. Also, it warrants a need to determine such tumor suppression involvement of 
HDAC3 in various other human cancers and a further possible need to profile cancer 























CHAPTER 5  
CONCLUSION AND PESPECTIVES 
 
In this thesis, I demonstrate that the Drosophila SWI/SNF complex regulates type 
II neuroblast homeostasis. Loss of Brm complex activity either by RNAi knock down or 
generation of homozygous mutant clones of various components of Brm complex 
including Brm, Bap60, Bap55, Snr1 and Mor resulted in type II neuroblast over-growth 
phenotype. However, loss of brm did not disrupt the apical localization of aPKC and 
basal localization of Brat and Numb. This suggests that Brm is not important for the 
regulation of apico-basal polarity of neuroblasts and that the neuroblast over-growth 
phenotype is independent of asymmetric division machinery. In addition to ectopic 
neuroblasts formation, loss of brm, mor and bap60 resulted in an expanded immature 
INP population and a shrunken mature INP population, suggesting reversion of INP back 
into neuroblast fate through de-differentiation. Consistently, knock down of brm 
specifically in INPs resulted in neuroblast formation within INP clones, supporting the 
notion that Brm suppresses de-differentiation of INP.  
Furthermore, among the 43 histone modifiers screened, HDAC3 is the only 
histone modifier that genetically enhanced the neuroblast over-growth phenotype of brm. 
Moreover, snr16Chdac36C double mutant showed significant enhancement of neuroblast 
overgrowth phenotype over snr1R3 single mutant, implying the co-functioning of HDAC3 
with Brm complex in regulating type II neuroblast homeostasis.  
In addition, Brm physically associates with HDAC3 in vitro, which further 
strengthen the notion that Brm and HDAC3 act synergistically to regulate neuroblast 
homeostasis. Further, various components of Brm complex including Brm, Bap60 and 
Snr1, as well as HDAC3 physically associated with type II specific zinc finger 
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transcription factor Earmuff (Erm) in vitro. Erm was reported as an INP specific 
transcription factor in type II lineages that suppresses de-differentiation and induces 
differentiation (Weng et al, 2010).  Thus, the type II specific function of Brm complex and 
HDAC3 is likely conferred by the physical interaction with Erm as co-factor. Double 
knock down of erm with brm, snr1 or hdac3 resulted in significantly enhanced neuroblast 
over-growth phenotype. Furthermore, loss of brm suppressed premature differentiation 
of neuroblast induced by ectopic expression of Erm. Together, these data support the 
hypothesis that the Brm-HDAC3-Erm complex functions specifically in type II lineages to 
regulate neuroblast homeostasis. 
However, it is uncertain which Brm sub-complex is involved. From the body of 
evidence obtained thus far, it is possible that both the BAP and PBAP are involved, 
albeit at different stages during the development of INPs. Thus, it will be of interest to 
determine the involvement of BAP and PBAP and at what developmental state they are 
involved. Further, the downstream targets of the Brm-HDAC3-Erm complex remain 
elusive. While de-differentiation was implicated in cancer formation in tissue cultures and 
mouse model (Friedmann-Morvinski, 2014; Friedmann-Morvinski and Verma, 2014), the 
mechanism underlying the process remains elusive. As such, identifying the downstream 
targets of the novel Brm-HDAC3-Erm complex would provide valuable insights into the 
mechanisms underlying de-differentiation particularly in the formation of glioblastoma. 
Such understanding could also provide a good start to identifying anti-cancer therapeutic 
targets. In addition, the tumor suppressor-like role of Drosophila HDAC3 demonstrated 
here is unexpected. It is possible that this tumor-suppressor-like role of HDAC3 was 
overlooked in the past or it is specific for the nervous system. Thus, it will be interesting 
to determine if mammalian HDAC3 play similar regulatory roles in maintaining the neural 
stem cell homeostasis and in suppressing de-differentiation. Understanding the role of 
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HDAC3 in mammalian system may be important to fine-tune the use of HDAC inhibitors 
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Table 1: Q-PCR results of potential downstream targets in brm or erm knock down 
Gene elav > brm RNAi  elav > erm RNAi 
Chm 0.889 1.239 
Cic 0.978 1.05 
CG2051 0.915 0.805 
Ciao1 0.922 0.927 
Mnt 1.543 1.201 
CG13919 0.857 0.674 
Grh 1.387 0.625 
Tws 0.962 0.899 
SAK 0.775 0.836 
Zfh1 0.976 1.732 
Brm 0.704  -  
AOP 1.25 0.796 
Tap42 0.949 1.081 
BEAF32 0.983 1.087 
Dfd 1.173 1.403 
CG32767 1.151 1.819 
CG18292 1.106 1.133 
Su(Var)205 0.996 1.19 
SSb-C31a 1.021 0.639 
Pax 1.154 1.108 
Shn 1.129 0.564 
Adf1 1.245 1.116 
CG1845 0.742 1.078 
Dpa 0.832 0.855 
Apt 0.826 0.869 
Ago 1.018 1.703 
SrpRBeta 0.835 0.711 
Pb 1.915 30.474 
Sim 0.916 0.975 
CG7379 0.9 1.282 
CG17803 0.907 1.183 
MED17 0.788 1.049 
CG12333 0.906 0.811 
Crol 0.978 0.914 
Lilli 0.845 1.087 
Rept 0.779 1.83 
Rab8 0.868 0.939 
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SF1 0.829 1.077 
Rpn5 0.911 1.071 
mpp6 0.82 0.715 
CG43346 1.019 1.188 
Rich 0.839 0.506 
CG8481 0.785 0.586 
Cdk12 0.927 0.831 
CG7372 0.824 0.693 
CG6272 1.055 0.38 
CG6241 0.735 0.661 
hiw 0.824 0.599 
Pgk 0.649 0.152 
CG1785 0.765 0.509 
CG17260 0.797 0.973 
Drat 0.868 0.29 
Erm  -  1.032 
 
 
 
 
